syndrome	score	normalized_score
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	2.004925512	100.0
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	1.7527353499999998	87.42146975084229
DIBASIC AMINO ACIDURIA I	1.642857	81.94104918946236
MEVALONIC ACIDURIA; MEVA	1.502119392	74.92145633388499
NEUROBLASTOMA, SUSCEPTIBILITY TO	1.5	74.81574707000887
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	1.4950579000000002	74.56924913427908
SACCHAROPINURIA	1.4761900000000001	73.62817177818425
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	1.398161102	69.73631158023791
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	1.299159752	64.79840493944495
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	1.25	62.34645589167405
#150250 LARSEN SYNDROME; LRS	1.22146219	60.923070841746075
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	1.113896632	55.558005787897834
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	1.094937692	54.61238761472751
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	1.072272482	53.48191120229509
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	1.05307805	52.5245473558521
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	1.04917858	52.33005284836737
OSTEOGENESIS IMPERFECTA, TYPE V	1.04111863	51.928045394636094
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	1.03559555	51.65256982375115
DICARBOXYLICAMINO ACIDURIA	1.0217391	50.96144938475899
JOINT LAXITY, FAMILIAL	1.0208333	50.91627064896166
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.0177110320000002	50.760540773646476
OMODYSPLASIA 1; OMOD1	1.00515464	50.13426354165721
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	1.00446022	50.09962784093697
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	1.00318471	50.03600901857346
YOU-HOOVER-FONG SYNDROME; YHFS	1.002119392	49.98287397721538
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	1.00194175	49.97401369792137
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	1.00127551	49.94078353570275
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	1.00127551	49.94078353570275
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	1.000843882	49.91925515485187
HARTNUP DISORDER	1.000843882	49.91925515485187
PENTOSURIA	1.0	49.87716471333924
THYROTROPIN-RELEASING HORMONE DEFICIENCY	1.0	49.87716471333924
PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES	1.0	49.87716471333924
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	1.0	49.87716471333924
BUTYRYLCHOLINESTERASE	1.0	49.87716471333924
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	1.0	49.87716471333924
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	1.0	49.87716471333924
#276880 UROCANASE DEFICIENCY	1.0	49.87716471333924
RADIAL HEADS, POSTERIOR DISLOCATION OF	1.0	49.87716471333924
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	1.0	49.87716471333924
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.9242421	46.098575456702555
HAWKINSINURIA	0.833333	41.56428730206113
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.75	37.407873535004434
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.643700882	32.10597491763574
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.642857	32.06388447612312
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.57236775	28.54808054335337
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.5217391	26.022867028089376
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.517991992	25.835971905174702
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.5167164820000001	25.772353082811193
TRYPTOPHANURIA WITH DWARFISM	0.50990099	25.432415665724744
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.50903395	25.389170168831686
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.50715271	25.295339251486364
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.505304102	25.203135925779975
LEBER CONGENITAL AMAUROSIS, TYPE I	0.50318471	25.09742666190384
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.502785632	25.07752178276437
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.502119392	25.044291620545756
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.50127551	25.002201179033136
HYPERTRYPTOPHANEMIA; HYPTRP	0.500843882	24.98067279818224
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.500843882	24.98067279818224
KETOADIPICACIDURIA	0.500843882	24.98067279818224
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.500843882	24.98067279818224
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	24.93858235666962
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.5	24.93858235666962
THREONINEMIA	0.5	24.93858235666962
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.5	24.93858235666962
JOUBERT SYNDROME 26	0.4942752819999999	24.6530496540462
HYPERPROLINEMIA, TYPE I	0.48460998200000005	24.170971893942365
IMINOGLYCINURIA	0.4837661	24.12888145242974
HYPERPROLINEMIA, TYPE II	0.4837661	24.12888145242974
DIAMINOPENTANURIA	0.47619	23.751007064845012
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.4520201	22.545480981440075
SMITH-MAGENIS SYNDROME; SMS	0.44204033200000004	22.047718449103165
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.441040922	21.997870711917002
PSEUDODIASTROPHIC DYSPLASIA	0.42618385000000003	21.256842084615066
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.39991463	19.94660787178412
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.39473329999999995	19.688177821939952
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.392857	19.594593297788315
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.372638382	18.586145957526227
CYSTINOSIS, NEPHROPATHIC; CTNS	0.36429571	18.170037132032864
WEBB-DATTANI SYNDROME; WEDAS	0.363763982	18.143516046994172
SECKEL SYNDROME 7; SCKL7	0.35786430999999996	17.849257134895495
HYPOTONIA-CYSTINURIA SYNDROME	0.351418282	17.5277475345927
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.3508769	17.50074493540586
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.3505744	17.485657093080075
RHYNS SYNDROME; RHYNS	0.3505744	17.485657093080075
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.344077872	17.161628695959255
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.3409091	17.00357933297624
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.3404252	16.979443772971454
PENDRED SYNDROME	0.33741463	16.829285077200414
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.337361892	16.826654655287765
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.33611863200000003	16.76464437148626
DESBUQUOIS DYSPLASIA 1	0.33527475	16.722553929973635
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.333333	16.625704945391508
MUSCULAR DYSTROPHY, CARDIAC TYPE	0.333333	16.625704945391508
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.333333	16.625704945391508
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.333333	16.625704945391508
HISTIDINEMIA	0.333333	16.625704945391508
HOMOCARNOSINOSIS	0.333333	16.625704945391508
TYROSINE TRANSAMINASE DEFICIENCY	0.333333	16.625704945391508
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.333333	16.625704945391508
CARNOSINEMIA	0.333333	16.625704945391508
CYSTATHIONINURIA	0.333333	16.625704945391508
CAMPTODACTYLY 1; CAMPD1	0.27777799999999997	13.854779059741945
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.27368943	13.65085278040993
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.27127551	13.530453294965106
OCULOECTODERMAL SYNDROME; OES	0.261616502	13.048689361981644
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.25515464	12.726390006652776
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.252785632	12.608230604429558
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.25194175	12.56614016291694
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.250843882	12.511381619847434
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.250843882	12.511381619847434
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.25	12.46929117833481
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.25	12.46929117833481
%169000 PATELLA, FAMILIAL RECURRENT DISLOCATION OF	0.25	12.46929117833481
WIDOW&#39;S PEAK SYNDROME	0.25	12.46929117833481
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.25	12.46929117833481
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.22173910000000002	11.059717614087603
BARTH SYNDROME; BTHS	0.20434529	10.192163687725074
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.204028592	10.17636768941469
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.20396184999999997	10.17303878768739
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.20318471000000002	10.134277247902068
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.20318471000000002	10.134277247902068
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.20286398199999997	10.118280244617885
RIBOFLAVIN DEFICIENCY	0.2	9.97543294266785
NEPHROLITHIASIS, CALCIUM OXALATE	0.2	9.97543294266785
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.2	9.97543294266785
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.2	9.97543294266785
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.2	9.97543294266785
#613616 HYPEROXALURIA, PRIMARY, TYPE III; HP3	0.2	9.97543294266785
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.188538122	9.403746965737648
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.18381511	9.16817651827057
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.183383482	9.146648137419682
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.18039707999999996	8.997694872965434
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.179894	8.97260266894145
PALLISTER-HALL SYNDROME	0.17890596199999995	8.923322134872407
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.17586768199999997	8.771781342867165
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.16794251000000002	8.376496233641625
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.16794251000000002	8.376496233641625
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.167510882	8.354967852790733
HYPERTAURINURIC CARDIOMYOPATHY	0.166667	8.312877411278112
HYPER-BETA-ALANINEMIA	0.166667	8.312877411278112
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.16221779199999997	8.090963531018202
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.1577824	7.869738753665977
GLUTARIC ACIDEMIA I; GA1	0.14604171	7.284146424687722
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.14519579999999999	7.241954832285061
HOLOPROSENCEPHALY 7	0.14370088199999997	7.1673925609661255
PANHYPOPITUITARISM, X-LINKED	0.14285699999999998	7.125302119453503
HYDROXYLYSINURIA	0.14285699999999998	7.125302119453503
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.14285699999999998	7.125302119453503
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.14285699999999998	7.125302119453503
LYSINE MALABSORPTION SYNDROME	0.14285699999999998	7.125302119453503
FAMILIAL EXPANSILE OSTEOLYSIS	0.14285699999999998	7.125302119453503
BRUCK SYNDROME 2	0.14285699999999998	7.125302119453503
KOOLEN-DE VRIES SYNDROME; KDVS	0.133789782	6.673054993775749
BOHRING-OPITZ SYNDROME	0.13157133199999999	6.562404997717442
MEIER-GORLIN SYNDROME 1; MGORS1	0.12922161000000001	6.445207526492886
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.125576092	6.263379424741442
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.12393149999999999	6.181351838671201
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.12313138199999998	6.141444221395094
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.12231205000000002	6.100578264276186
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.12185587199999999	6.077825399031583
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.12185587199999999	6.077825399031583
GENITOPATELLAR SYNDROME; GTPTS	0.11853283200000002	5.91208158560257
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.11557121999999997	5.764364776061566
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.11513959199999999	5.742836395210676
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.11513959199999999	5.742836395210676
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.11444179000000002	5.70803200991938
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.11305275	5.638750633045962
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.11291762999999999	5.632011230549896
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.11195488199999999	5.583992089976459
Cerebral creatine deficiency syndrome 3	0.11195488199999999	5.583992089976459
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.11195488199999999	5.583992089976459
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.11195488199999999	5.583992089976459
ATELOSTEOGENESIS, TYPE I; AO1	0.11131730000000001	5.552191307544199
CHROMOSOME 1P36 DELETION SYNDROME	0.11121782200000002	5.547229626952846
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.11111099999999999	5.541901648463836
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.11111099999999999	5.541901648463836
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.11111099999999999	5.541901648463836
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.11111099999999999	5.541901648463836
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.11111099999999999	5.541901648463836
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.10968495	5.470774317724379
KAPUR-TORIELLO SYNDROME	0.10541957000000002	5.258029256899397
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.104585382	5.216422324621505
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.10408163000000001	5.191296603142832
LARON SYNDROME	0.10408163000000001	5.191296603142832
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.10325480000000001	5.150056667042901
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.10318471	5.146560776568142
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.10167752200000002	5.071386512438175
BOWEN-CONRADI SYNDROME	0.10127551	5.051335293697436
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.10081009	5.028121463696554
KENNERKNECHT SYNDROME	0.1	4.987716471333925
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.1	4.987716471333925
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.1	4.987716471333925
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.1	4.987716471333925
CORACOCLAVICULAR JOINT, ANOMALOUS	0.1	4.987716471333925
METACHONDROMATOSIS	0.1	4.987716471333925
KABUKI SYNDROME 1	0.09709898200000001	4.843021918711562
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0960528	4.790841326777431
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.737868286450335
PROPIONIC ACIDEMIA	0.094937692	4.735222901388269
Contractural arachnodactyly, congenital	0.09410592000000001	4.693736472340326
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09401158200000001	4.689031160375599
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0931595	4.646531726112327
MEIER-GORLIN SYNDROME 5; MGORS5	0.09218461	4.597906977004939
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.09218461	4.597906977004939
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.09175298200000001	4.576378596154051
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.0915301	4.565261873928412
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.0909091	4.534288154641429
SITOSTEROLEMIA	0.0909091	4.534288154641429
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.0909091	4.534288154641429
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	4.534288154641429
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0909091	4.534288154641429
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.534288154641429
GLUCOGLYCINURIA	0.0909091	4.534288154641429
GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS	0.0909091	4.534288154641429
GLYCINE ENCEPHALOPATHY; GCE	0.0909091	4.534288154641429
RCAD (renal cysts and diabetes)	0.0909091	4.534288154641429
ATRANSFERRINEMIA	0.0909091	4.534288154641429
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.0909091	4.534288154641429
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.088637402	4.420982299316465
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.08784078	4.3812490526081955
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.08545269200000001	4.262137994082247
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.08527505000000002	4.25327771478824
NAIL-PATELLA SYNDROME	0.08527505000000002	4.25327771478824
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.08417718200000002	4.198519171718735
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.08417718200000002	4.198519171718735
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.08417718200000002	4.198519171718735
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.08364726	4.172088164839513
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.08333330000000001	4.156428730206114
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.08333330000000001	4.156428730206114
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.08333330000000001	4.156428730206114
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.08333330000000001	4.156428730206114
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.08333330000000001	4.156428730206114
SENGERS SYNDROME	0.08333330000000001	4.156428730206114
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.08333330000000001	4.156428730206114
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.08333330000000001	4.156428730206114
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.082522462	4.115986429724279
POTOCKI-LUPSKI SYNDROME	0.080175342	3.9989187388823053
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.07806296	3.8935591139308126
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.07638890000000001	3.8100617475708005
PYGMY	0.07551023000000001	3.7662361792521306
ALKAPTONURIA	0.07551023000000001	3.7662361792521306
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.07551023000000001	3.7662361792521306
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.07551023000000001	3.7662361792521306
METHYLMALONIC ACIDURIA, CBLB TYPE	0.075457192	3.7635907941900646
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.075457192	3.7635907941900646
METHYLMALONIC ACIDURIA, CBLA TYPE	0.075457192	3.7635907941900646
HYDROXYKYNURENINURIA	0.075214582	3.7514900952589607
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.074985982	3.740088175405492
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.074557392	3.7187113213810012
ROWLEY-ROSENBERG SYNDROME	0.0743707	3.7093996537463383
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.074218092	3.701787999393765
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.07365225	3.6735654047580404
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.07270411	3.6262748698067346
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.07250788	3.616487473775036
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.07227248200000001	3.6047464889558465
FONTAINE PROGEROID SYNDROME; FPS	0.07221568	3.6019133662457987
ERYTHERMALGIA, PRIMARY	0.0714995	3.5661923384213985
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.07142860000000001	3.5626560474432236
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.07142860000000001	3.5626560474432236
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.07142860000000001	3.5626560474432236
SCALP-EAR-NIPPLE SYNDROME; SENS	0.07142860000000001	3.5626560474432236
MYASTHENIA GRAVIS; MG	0.07142860000000001	3.5626560474432236
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.07142860000000001	3.5626560474432236
Split hand/foot malformation 1 (SHFM1)	0.07142860000000001	3.5626560474432236
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.07142860000000001	3.5626560474432236
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.07142860000000001	3.5626560474432236
BIEMOND SYNDROME II	0.07142860000000001	3.5626560474432236
274210 THYMIC APLASIA WITH FETAL DEATH	0.07142860000000001	3.5626560474432236
#613646 METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT;;METHYLMALONIC ACIDEMIA, TCblR TYPE	0.07142860000000001	3.5626560474432236
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.07142860000000001	3.5626560474432236
MECKEL SYNDROME, TYPE 5	0.07142860000000001	3.5626560474432236
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.07142860000000001	3.5626560474432236
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.07142860000000001	3.5626560474432236
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.07142860000000001	3.5626560474432236
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.07142860000000001	3.5626560474432236
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.07142860000000001	3.5626560474432236
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.07142860000000001	3.5626560474432236
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.07142860000000001	3.5626560474432236
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.07044027200000001	3.513361048996419
OCULOSKELETODENTAL SYNDROME; OCSKD	0.069264542	3.454718970128004
LARSEN-LIKE SYNDROME	0.067425512	3.3629933679052324
EHLERS-DANLOS SYNDROME, TYPE VI	0.06658163	3.3209029263926095
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.066561142	3.3198810430419625
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.06609388199999999	3.2965754390580075
FRANK-TER HAAR SYNDROME; FTHS	0.0648411	3.2340902248941013
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.064619392	3.2230320584598355
CORNELIA DE LANGE SYNDROME 1	0.06434941	3.2095661217761995
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0641259	3.1984180766911208
CATEL-MANZKE SYNDROME; CATMANS	0.063343882	3.159413236096325
RAPADILINO SYNDROME	0.0625	3.1173227945837025
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.0625	3.1173227945837025
EHLERS-DANLOS SYNDROME, TYPE I	0.0625	3.1173227945837025
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.0625	3.1173227945837025
FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	0.0625	3.1173227945837025
MEESTER-LOEYS SYNDROME; MRLS	0.0625	3.1173227945837025
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0625	3.1173227945837025
COFFIN-SIRIS SYNDROME 2; CSS2	0.062429182	3.1137905935330332
PHACE ASSOCIATION	0.062017462	3.0932551672772575
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.06113861	3.0494205213146097
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.060567682	3.0209442514191522
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0597238	2.9788538099065303
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.059637230000000006	2.9745359437572967
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.059637230000000006	2.9745359437572967
FETAL IODINE DEFICIENCY DISORDER	0.059637230000000006	2.9745359437572967
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.059584192	2.9718905586952302
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.05941691	2.9635470068276537
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.059374732000000006	2.9614432877743746
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	2.936253723524867
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.05824958	2.9053238961428316
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.057770690000000006	2.8814382207332607
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0574452	2.8652037023907155
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.057394442000000004	2.862672037264196
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.8594279267169105
COFFIN-SIRIS SYNDROME 4; CSS4	0.057140741999999994	2.850018200576421
COFFIN-SIRIS SYNDROME 3; CSS3	0.057140741999999994	2.850018200576421
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.057061390000000003	2.846060347802089
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.05671323	2.8286951141354924
SILVER-RUSSELL SYNDROME; SRS	0.056546782000000004	2.8203931598232868
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.056527132	2.8194130735366696
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.056399482	2.8130462534610117
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.05581631	2.783959287560804
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.055662222	2.7762738150044552
PRIMROSE SYNDROME; PRIMS	0.055555600000000004	2.7709558119483897
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.055555600000000004	2.7709558119483897
#275200 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1;;THYROTROPIN RESISTANCE;;THYROID-STIMULATING HORMONE, RESISTANCE TO; RTSH;;TSH RESISTANCE;;HYPOTHYROIDISM, NONAUTOIMMUNE;;HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE;;HYPOTHYROIDISM DUE TO UNRESPONSIVENESS TO THYROTROPIN	0.055555600000000004	2.7709558119483897
THYROID DYSHORMONOGENESIS 6; TDH6	0.055555600000000004	2.7709558119483897
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.055555600000000004	2.7709558119483897
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.055555600000000004	2.7709558119483897
C SYNDROME	0.055512532	2.7688077022185156
COWDEN SYNDROME 6; CWS6	0.05532865	2.7596361894166974
COWDEN SYNDROME 5; CWS5	0.05532865	2.7596361894166974
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.055227112	2.754571761866034
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.722405379816425
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.05457335	2.721963966908712
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.05423121000000001	2.7048989937736905
AURICULOOSTEODYSPLASIA	0.0535588	2.6713610894487934
NETHERTON SYNDROME; NETH	0.053475482	2.667205423839208
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.05295570000000001	2.641280171410179
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0526316	2.625114982326586
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.0526316	2.625114982326586
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	2.625114982326586
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0526316	2.625114982326586
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	2.625114982326586
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0526316	2.625114982326586
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	2.625114982326586
THROMBOCYTOPENIA 1	0.0526316	2.625114982326586
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.052444962	2.6158060080588172
COFFIN-SIRIS SYNDROME 1; CSS1	0.052228962	2.605032540480736
PETERS-PLUS SYNDROME; PTRPLS	0.051870762	2.587166540080418
CHROMOSOME 18Q DELETION SYNDROME	0.051231280000000004	2.5552709910352025
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.050983102	2.5428925760509755
ACROCALLOSAL SYNDROME; ACLS	0.050877200000000004	2.5376104845535035
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.050807200000000004	2.5341190830235694
ACRORENAL-MANDIBULAR SYNDROME	0.050807200000000004	2.5341190830235694
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.050799652	2.533742610184313
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.049922732	2.490004326903892
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.04974014200000001	2.4808972553988835
HAMAMY SYNDROME; HMMS	0.04968704	2.4782486781982755
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.049597362	2.4737757938211127
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.049597362	2.4737757938211127
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.04909567	2.448752819301748
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0485348	2.4207782139289775
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.04780334	2.384295063027758
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.04693799	2.34113385854307
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.04693799	2.34113385854307
MOEBIUS SYNDROME; MBS	0.04693799	2.34113385854307
CHOPS SYNDROME; CHOPS	0.04688736200000001	2.3386086774479637
CAMPOMELIC DYSPLASIA	0.0468388	2.3361865425751542
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.0468388	2.3361865425751542
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.046821339999999996	2.335315687279259
TYSHCHENKO SYNDROME	0.046406722	2.3146357170001437
CHARGE SYNDROME	0.046156680000000005	2.3021643309808915
SECKEL SYNDROME 1; SCKL1	0.04586596	2.287664041655429
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0455537	2.272089398202042
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.04502701	2.245819594319173
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.04480203000000001	2.2345982298019664
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.044768091999999995	2.2329054985859247
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.04459045	2.2240452192919173
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.04459045	2.2240452192919173
RITSCHER-SCHINZEL SYNDROME 1	0.044516522	2.22035790025899
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.044370932	2.213096283848375
TIMOTHY SYNDROME; TS	0.044114561999999996	2.200309275130816
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.043847910000000004	2.187009429405675
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.043492582	2.1692866762224137
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.043400480000000005	2.1646928895979856
KBG SYNDROME	0.043395992	2.1644690408827523
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.043322152	2.160786111040319
PRADER-WILLI SYNDROME; PWS	0.043282832	2.1588249409237905
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.04321835	2.155608761588745
CORNELIA DE LANGE SYNDROME 3	0.043110802000000004	2.150244572278155
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.0426487	2.1271962347097912
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.042647642	2.1271434646695244
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.042552110000000004	2.12237859937013
300270 ADRENOMYODYSTROPHY	0.04251058199999999	2.1203073004739137
Helsmoortel-van der Aa syndrome	0.042126682	2.1011594569404632
MEIER-GORLIN SYNDROME 6; MGORS6	0.041772710000000005	2.0835043371925535
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.041736912	2.0817188344501454
#226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMYLOSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIACUTIS CONGENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	0.041666699999999994	2.0782168589612917
GENITOURINARY TRACT ANOMALIES	0.041666699999999994	2.0782168589612917
FRYNS MICROPHTHALMIA SYNDROME	0.041666699999999994	2.0782168589612917
URINARY BLADDER, ATONY OF	0.041666699999999994	2.0782168589612917
VISCERAL STEATOSIS, CONGENITAL	0.041666699999999994	2.0782168589612917
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.041666699999999994	2.0782168589612917
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.041666699999999994	2.0782168589612917
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.041666699999999994	2.0782168589612917
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.041666699999999994	2.0782168589612917
ADENOMYOSIS	0.041666699999999994	2.0782168589612917
DK PHOCOMELIA SYNDROME	0.041666699999999994	2.0782168589612917
OVARIAN HYPERSTIMULATION SYNDROME	0.041666699999999994	2.0782168589612917
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.041666699999999994	2.0782168589612917
HYPERLYSINEMIA, TYPE I	0.041666699999999994	2.0782168589612917
GALACTORRHEA	0.041666699999999994	2.0782168589612917
LABIA MINORA, INCOMPLETE ADHESION OF	0.041666699999999994	2.0782168589612917
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.041666699999999994	2.0782168589612917
TESTICULAR TORSION	0.041666699999999994	2.0782168589612917
NATHALIE SYNDROME	0.041666699999999994	2.0782168589612917
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.041666699999999994	2.0782168589612917
207620 APHALANGY WITH HEMIVERTEBRAE	0.041666699999999994	2.0782168589612917
PEYRONIE DISEASE	0.041666699999999994	2.0782168589612917
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.041589140000000004	2.074348386066126
SCARF SYNDROME	0.0412766	2.0587597770066184
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.04126938200000001	2.058399763631718
COFFIN-SIRIS SYNDROME 7; CSS7	0.04126938200000001	2.058399763631718
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.040860332	2.037997509405726
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.04076225	2.0331054573363128
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.04025426	2.0077683564335835
MECKEL SYNDROME, TYPE 1; MKS1	0.040226790000000005	2.006398230718908
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.04022171	2.006144854722164
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.04013391	2.001765639660333
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03985024000000001	1.9876169843461005
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.039849209999999996	1.987565610866445
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.9849081555305188
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.9849081555305188
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.9849081555305188
EMANUEL SYNDROME	0.039748692	1.9825520580237899
COACH SYNDROME	0.039742892	1.9822627704684526
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.03929356	1.9598513642934783
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.039227222	1.9565426129407246
PYCNODYSOSTOSIS	0.03897875	1.9441495340700716
CARTILAGE-HAIR HYPOPLASIA; CHH	0.03897875	1.9441495340700716
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.03897875	1.9441495340700716
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.038951280000000005	1.9427794083553969
WITTEVEEN-KOLK SYNDROME	0.038846442	1.9375503861611794
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.038811241999999996	1.9357947099632697
PALLISTER-KILLIAN SYNDROME	0.03869812	1.9301525053365676
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.038596950000000005	1.9251064325825191
THUMBS, CONGENITAL CLASPED	0.0384757	1.9190588263610266
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.9183505706220974
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.9183505706220974
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.9183505706220974
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.9183505706220974
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.9183505706220974
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.9183505706220974
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.9183505706220974
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	1.9183505706220974
BETHLEM MYOPATHY 1	0.0384615	1.9183505706220974
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.9183505706220974
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.9183505706220974
ARTERIES, ANOMALIES OF	0.0384615	1.9183505706220974
THUMB DEFORMITY	0.0384615	1.9183505706220974
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.9183505706220974
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.9183505706220974
WATSON SYNDROME	0.0384615	1.9183505706220974
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.038420772000000006	1.9163191734576528
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.0383772	1.9141459256367628
CHROMOSOME 10Q26 DELETION SYNDROME	0.038250242000000004	1.9078136205590865
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.038195691999999996	1.9050928212239737
ALSTROM SYNDROME; ALMS	0.038137142	1.9021725132300076
FLOATING-HARBOR SYNDROME	0.03792554	1.8916184054223362
MUCOLIPIDOSIS IV; ML4	0.037833692	1.8870372875977455
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.037395199999999996	1.8651665498882635
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.037394442	1.8651287429974108
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.037394442	1.8651287429974108
ZTTK SYNDROME; ZTTKS	0.037278731999999995	1.85935745626843
BEEMER LETHAL MALFORMATION SYNDROME	0.0371517	1.8530214602805657
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.037037	1.8473005494879453
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.037037	1.8473005494879453
EXSTROPHY OF BLADDER	0.037037	1.8473005494879453
OSTEOARTHRITIS	0.037037	1.8473005494879453
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.037037	1.8473005494879453
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.037037	1.8473005494879453
HYPOCHONDROPLASIA	0.037037	1.8473005494879453
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.037037	1.8473005494879453
SCLEROSTEOSIS 1; SOST1	0.037037	1.8473005494879453
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.037037	1.8473005494879453
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.037037	1.8473005494879453
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.036612492	1.8261272940498154
WHITE-SUTTON SYNDROME; WHSUS	0.036612492	1.8261272940498154
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.036612492	1.8261272940498154
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.03643485	1.8172670147558083
LOWE OCULOCEREBRORENAL SYNDROME	0.03602655	1.7969021684033515
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.035768610000000006	1.7840368525371937
FANCONI ANEMIA	0.035768610000000006	1.7840368525371937
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.035768610000000006	1.7840368525371937
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.035768610000000006	1.7840368525371937
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7813280237216118
219400 CYANOSIS AND HEPATIC DISEASE	0.035714300000000004	1.7813280237216118
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7813280237216118
TERATOMA, PINEAL	0.035714300000000004	1.7813280237216118
METHANE PRODUCTION	0.035714300000000004	1.7813280237216118
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7813280237216118
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.035714300000000004	1.7813280237216118
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.035714300000000004	1.7813280237216118
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7813280237216118
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7813280237216118
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7813280237216118
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.7813280237216118
BLUE DIAPER SYNDROME	0.035714300000000004	1.7813280237216118
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.7813280237216118
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7813280237216118
GASTRIC SNEEZING	0.035714300000000004	1.7813280237216118
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7813280237216118
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.035452692	1.7682797584152845
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.035452692	1.7682797584152845
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.035452692	1.7682797584152845
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.035336981999999996	1.7625084716863038
KAGAMI-OGATA SYNDROME	0.035209411999999995	1.7561456417838228
RECOMBINANT CHROMOSOME 8 SYNDROME	0.034834852	1.7374636509687946
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.034834852	1.7374636509687946
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.034823179999999995	1.7368814847022604
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.03480822	1.7361353223181493
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.0344931	1.7204180301736816
184705 STEINFELD SYNDROME	0.0344931	1.7204180301736816
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0344931	1.7204180301736816
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0344931	1.7204180301736816
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0344931	1.7204180301736816
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0344931	1.7204180301736816
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0344931	1.7204180301736816
COFFIN-SIRIS SYNDROME 5	0.034366232000000003	1.7140902140408298
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.03436414199999999	1.7139859707665788
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.034286192	1.7100980457771742
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.034177182	1.704660936051773
NOONAN SYNDROME 9; NS9	0.034177182	1.704660936051773
CHROMOSOME 15q25 DELETION SYNDROME	0.034177182	1.704660936051773
NOONAN SYNDROME 2; NS2	0.034177182	1.704660936051773
YUNIS-VARON SYNDROME	0.03402941	1.6972904876677537
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.033613692	1.6765556525074536
ALAZAMI-YUAN SYNDROME	0.033613692	1.6765556525074536
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.033613692	1.6765556525074536
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.033604252	1.6760848120725598
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.03359042	1.6753949111302446
CRI-DU-CHAT SYNDROME	0.033581660000000006	1.674957987167356
COSTELLO SYNDROME; CSTLO	0.033498921999999993	1.6708312503133032
NOONAN SYNDROME 10; NS10	0.0333333	1.662570494539151
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.0333333	1.662570494539151
BARAITSER-WINTER SYNDROME 1; BRWS1	0.033095602	1.6507147922411196
STEEL SYNDROME; STLS	0.03308863199999999	1.6503671484030673
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.0327709	1.6345195771043688
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.032769809999999996	1.6344652109948312
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.032655039999999996	1.6287408088006814
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.032422391999999994	1.617136986184452
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.032406422	1.6163404478639805
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.032406422	1.6163404478639805
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.032373872	1.6147169461525612
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.032373872	1.6147169461525612
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.032338182	1.6129368301439424
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.032338182	1.6129368301439424
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.032244749999999996	1.6082767068904453
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.032244749999999996	1.6082767068904453
MEHMO SYNDROME; MEHMO	0.032181292	1.6051116017720664
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.032166799999999995	1.6043887819010405
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.032070972	1.599609152960891
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.03204922	1.5985242248740463
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.0319025	1.5912062472673052
HARDIKAR SYNDROME	0.03152999	1.572626504639939
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.03152999	1.572626504639939
TRANSALDOLASE DEFICIENCY	0.03152999	1.572626504639939
INFANTILE SIALIC ACID STORAGE DISEASE	0.031528992	1.5725767272295552
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.0314943	1.5708463886313202
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.031299692	1.5611398933607863
611961 STEVENSON-CAREY SYNDROME	0.031196072000000002	1.5559716215531905
RESTRICTIVE DERMOPATHY, LETHAL	0.031180819999999998	1.5552108950369823
KNIEST-LIKE DYSPLASIA, LETHAL	0.031180819999999998	1.5552108950369823
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.031146881999999997	1.5535181638209412
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.031130911999999997	1.552721625500469
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.031120792	1.5522168685935702
#300867 KABUKI SYNDROME 2; KABUK2	0.031114032000000003	1.551879698960108
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.03093061	1.542731129654058
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.03054179	1.5233378904702173
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.030529832000000003	1.5227414593345752
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.030464671999999998	1.519491463281854
RADIOULNAR SYNOSTOSIS	0.030302999999999997	1.5114277223083188
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.030302999999999997	1.5114277223083188
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.030302999999999997	1.5114277223083188
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.030302999999999997	1.5114277223083188
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.030302999999999997	1.5114277223083188
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.030302999999999997	1.5114277223083188
OMODYSPLASIA	0.030302999999999997	1.5114277223083188
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.03028703	1.510631183987847
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.03028703	1.510631183987847
#256520 NEU-LAXOVA SYNDROME; NLS	0.02962079	1.477401021769232
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.029619792	1.477351244358848
#170100 PROLIDASE DEFICIENCY	0.029386822	1.4657313612955813
ZIMMERMANN-LABAND SYNDROME 1	0.02933094	1.4629441255770705
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.029294900000000002	1.4611465525608018
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.029211592	1.456991385722863
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.029189161999999998	1.4558726409183427
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.029189161999999998	1.4558726409183427
MOWAT-WILSON SYNDROME; MOWS	0.02899733	1.4463046046570533
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.02891528	1.442212183292324
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0288313	1.4380234989996976
CODAS SYNDROME	0.028773571999999997	1.4351441900351258
EVEN-PLUS SYNDROME	0.028725821999999998	1.432762555420064
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.028487489999999997	1.4208752309996044
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0284435	1.4186811345238648
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.028410440000000002	1.4170321954584417
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.02839303	1.4161638340207825
NOONAN SYNDROME 7; NS7	0.02837299	1.415164295639927
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0283688	1.4149553103197783
HYPERTELORISM AND TETRALOGY OF FALLOT	0.02834528	1.4137821994057205
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.02834528	1.4137821994057205
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.02834528	1.4137821994057205
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.028233071999999998	1.408185582507566
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.027940272000000002	1.3935815486795005
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0279255	1.392844763202355
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02790185	1.3916651682568844
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.027901142	1.3916298552242674
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.027737622	1.3834739412503423
HADZISELIMOVIC SYNDROME	0.027274032	1.3603513864608852
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02726345	1.3598235863038888
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0270922	1.3512821218467295
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.026945781999999998	1.3439792071437315
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.026870062	1.3402025082316376
Diamond-Blackfan anemia 1	0.026838349999999997	1.338620803584248
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.026609222	1.3271925485878102
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.02647306	1.3204011740861126
SPONDYLOOCULAR SYNDROME; SOS	0.02643124	1.3183153110578008
HAREL-YOON SYNDROME; HAYOS	0.026041432	1.2988727932352233
AU-KLINE SYNDROME; AUKS	0.026041432	1.2988727932352233
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.026041432	1.2988727932352233
GALACTOSE EPIMERASE DEFICIENCY	0.025767692000000002	1.285219418166594
ARGININOSUCCINIC ACIDURIA	0.025767692000000002	1.285219418166594
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.025767692000000002	1.285219418166594
ROIFMAN SYNDROME; RFMN	0.025712302	1.282456722013122
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02558075	1.2758952812407527
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.025375192	1.2656426310166082
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.025375192	1.2656426310166082
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.025337742	1.2637747311980938
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.02531691	1.2627356901027853
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.02519755	1.256782351722601
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.02519755	1.256782351722601
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.02519755	1.256782351722601
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.02519755	1.256782351722601
LYSINURIC PROTEIN INTOLERANCE; LPI	0.02492381	1.2431289766539717
GALACTOSEMIA	0.02492381	1.2431289766539717
WILSON DISEASE	0.02492381	1.2431289766539717
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.02492381	1.2431289766539717
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.02492381	1.2431289766539717
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.024894442	1.2416641840806704
GAUCHER DISEASE, PERINATAL LETHAL	0.02486842	1.2403662805004998
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.024846692	1.2392825494656086
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.024489829999999997	1.2214832847116766
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02448588	1.2212862699110592
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.024437390000000003	1.2188677261941094
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.024239042	1.2089746903275478
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.024099682	1.202023808653097
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.024062232	1.2001559088345821
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.024062232	1.2001559088345821
CRANIOSYNOSTOSIS 6; CRS6	0.024061142	1.2001015427250448
#278250 WRINKLY SKIN SYNDROME; WSS	0.02405056	1.1995737425680482
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.02405056	1.1995737425680482
FOCAL DERMAL HYPOPLASIA; FDH	0.02405056	1.1995737425680482
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0240414	1.199116867739274
NF1-microdeletion syndrome	0.0240414	1.199116867739274
FUMARASE DEFICIENCY; FMRD	0.023858492000000002	1.1899939352958866
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.023858492000000002	1.1899939352958866
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.023858492000000002	1.1899939352958866
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.023858492000000002	1.1899939352958866
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.023712959999999998	1.1827352117608247
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.02368943	1.18156160207512
SPINAL ARACHNOIDITIS	0.02368943	1.18156160207512
NEPHROSIALIDOSIS	0.02368943	1.18156160207512
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02368943	1.18156160207512
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.023618932	1.178045361717159
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.023592909999999998	1.1767474581369886
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.023571182	1.1756637271020969
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.023571182	1.1756637271020969
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.023466492000000002	1.1704420867282577
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.023395992	1.1669257466159673
BARATELA-SCOTT SYNDROME	0.023395992	1.1669257466159673
DIGEORGE SYNDROME; DGS	0.023329011999999996	1.1635849741234674
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.0232558	1.1599333671404748
#613618 CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	0.0232558	1.1599333671404748
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0232558	1.1599333671404748
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0232558	1.1599333671404748
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.0232558	1.1599333671404748
CRANIOECTODERMAL DYSPLASIA 4	0.0232558	1.1599333671404748
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.0232558	1.1599333671404748
HIP DYSPLASIA, BEUKES TYPE	0.0232558	1.1599333671404748
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.02321835	1.1580654673219601
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.02321726	1.1580111012124226
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.02301461	1.1479034937832646
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.022952692	1.144815199498544
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.022952692	1.144815199498544
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.1446574879037203
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1446574879037203
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1446574879037203
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1446574879037203
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1446574879037203
LYMPHEDEMA, HEREDITARY, III	0.022865672	1.140474888625189
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.022785632	1.1364827203615333
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.022785632	1.1364827203615333
BRITTLE CORNEA SYNDROME	0.022775049999999998	1.135954920204537
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.022775049999999998	1.135954920204537
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.022775049999999998	1.135954920204537
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.022775049999999998	1.135954920204537
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0227273	1.133573285589475
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0227273	1.133573285589475
#611363 ATRIAL SEPTAL DEFECT 4; ASD4	0.0227273	1.133573285589475
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0227273	1.133573285589475
ADAMS-OLIVER SYNDROME 5; AOS5	0.0227273	1.133573285589475
LOEYS-DIETZ SYNDROME 5	0.0227273	1.133573285589475
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0227273	1.133573285589475
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0227273	1.133573285589475
FIBROCHONDROGENESIS 1; FBCG1	0.0227273	1.133573285589475
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.0227273	1.133573285589475
HURLER SYNDROME	0.022615092	1.1279766686913206
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.022582982	1.1263751129323754
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.022582982	1.1263751129323754
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.022582982	1.1263751129323754
#300555 DENT DISEASE 2	0.022582982	1.1263751129323754
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.022582982	1.1263751129323754
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.02255211	1.124835305103345
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.02255211	1.124835305103345
BRANCHIOOCULOFACIAL SYNDROME	0.02255211	1.124835305103345
TEMPLE SYNDROME	0.022349949999999997	1.114752137484896
#156550 KNIEST DYSPLASIA	0.02224669	1.109601821456597
MELNICK-NEEDLES SYNDROME	0.02224669	1.109601821456597
CRANIOFRONTONASAL SYNDROME; CFNS	0.022120482	1.1033069242524558
MENTAL RETARDATION, X-LINKED 91; MRX91	0.022120482	1.1033069242524558
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.022119392	1.1032525581429184
MACDERMOT-WINTER SYNDROME	0.022119392	1.1032525581429184
ADAMS-OLIVER SYNDROME 2; AOS2	0.022119392	1.1032525581429184
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02205261	1.0999216613290321
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.02180376	1.0875097288901177
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.02177121	1.0858862271786984
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.02177121	1.0858862271786984
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.02177121	1.0858862271786984
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.02177121	1.0858862271786984
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.0217391	1.0842846714197532
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0217391	1.0842846714197532
TIGLIC ACIDEMIA	0.0217391	1.0842846714197532
BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF	0.0217391	1.0842846714197532
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0217391	1.0842846714197532
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.0217391	1.0842846714197532
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0217391	1.0842846714197532
FORMIMINOTRANSFERASE DEFICIENCY	0.0217391	1.0842846714197532
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0217391	1.0842846714197532
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.0217391	1.0842846714197532
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.0217391	1.0842846714197532
DENT DISEASE 1	0.0217391	1.0842846714197532
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0217391	1.0842846714197532
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.0217391	1.0842846714197532
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.021677182	1.0811963771350324
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.021677182	1.0811963771350324
TRISOMY 18-LIKE SYNDROME	0.02162553	1.0786201218232592
JOHANSON-BLIZZARD SYNDROME; JBS	0.02135555	1.065154284893952
PTERYGIUM COLLI, ISOLATED	0.0212766	1.0612164827398336
LEGIUS SYNDROME	0.0212766	1.0612164827398336
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0212766	1.0612164827398336
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0212766	1.0612164827398336
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.0212766	1.0612164827398336
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0212766	1.0612164827398336
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0212766	1.0612164827398336
TEEBI-SHALTOUT SYNDROME; TBSH	0.02127551	1.0611621166302962
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.021252082	1.059993594415392
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.021252082	1.059993594415392
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.021252082	1.059993594415392
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.021252082	1.059993594415392
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.021252082	1.059993594415392
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.021010342	1.0479362886175896
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.020977792000000002	1.0463127869061704
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.020843882	1.039633735779407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020843882	1.039633735779407
Muenke syndrome	0.020843882	1.039633735779407
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.020843882	1.039633735779407
%107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6;;ANONYCHIA/HYPONYCHIA AND ONYCHODYSTROPHY;;ANONYCHIA, PARTIAL	0.0208333	1.0391059356224104
OCULOCEREBROCUTANEOUS SYNDROME	0.0208333	1.0391059356224104
ACETABULAR DYSPLASIAHIP, DISLOCATION OF, CONGENITAL, INCLUDED	0.0208333	1.0391059356224104
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0208333	1.0391059356224104
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0208333	1.0391059356224104
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0208333	1.0391059356224104
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0208333	1.0391059356224104
Rothmund-Thomson syndrome	0.0208333	1.0391059356224104
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0208333	1.0391059356224104
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.0208333	1.0391059356224104
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0208333	1.0391059356224104
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.0208333	1.0391059356224104
BRANCHIOOTORENAL SYNDROME 1	0.0208333	1.0391059356224104
PELVIS-SHOULDER DYSPLASIA	0.0208333	1.0391059356224104
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0208333	1.0391059356224104
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02080965	1.03792634067694
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.02080965	1.03792634067694
FRONTOMETAPHYSEAL DYSPLASIA	0.020528249999999998	1.023890906526606
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.02045866	1.020419954634205
BAND HETEROTOPIA; BH	0.020451682000000002	1.0200719117788355
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	1.0200719117788355
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.0179031529027698
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.0179031529027698
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.0179031529027698
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	1.0179031529027698
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.0179031529027698
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.0179031529027698
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	1.0179031529027698
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.0179031529027698
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.0179031529027698
NEMALINE MYOPATHY 10	0.020408199999999998	1.0179031529027698
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.0179031529027698
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.0179031529027698
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.0179031529027698
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.0179031529027698
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.0179031529027698
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.020329532	1.013979416109101
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.020229502	1.0089902033228257
WILLIAMS-BEUREN SYNDROME; WBS	0.02008004	1.0015354625304405
WARBURG MICRO SYNDROME 2; WARBM2	0.02	0.9975432942667848
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.02	0.9975432942667848
WARBURG MICRO SYNDROME 3; WARBM3	0.02	0.9975432942667848
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.019663292000000002	0.980749253890486
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.9779814702662133
HHHH SYNDROME	0.0196078	0.9779814702662133
LETTERER-SIWE DISEASE	0.0196078	0.9779814702662133
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.9779814702662133
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.9779814702662133
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.9779814702662133
TOE, MISSHAPEN	0.0196078	0.9779814702662133
MONOPHALANGY OF GREAT TOE	0.0196078	0.9779814702662133
RAYNAUD DISEASE	0.0196078	0.9779814702662133
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.9779814702662133
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.9779814702662133
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.9779814702662133
VESICOURETERAL REFLUX 1	0.0196078	0.9779814702662133
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.9779814702662133
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.9779814702662133
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.9779814702662133
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0196078	0.9779814702662133
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.9779814702662133
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.9779814702662133
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.9779814702662133
KNUCKLE PADS	0.0196078	0.9779814702662133
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.9779814702662133
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.9779814702662133
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.9779814702662133
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	0.9779814702662133
VAN DEN BOSCH SYNDROME	0.0196078	0.9779814702662133
PUBIC BONE DYSPLASIA	0.0196078	0.9779814702662133
MEGAEPIPHYSEAL DWARFISM	0.0196078	0.9779814702662133
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.9779814702662133
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.9779814702662133
#215300 CHONDROSARCOMA	0.0196078	0.9779814702662133
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.9779814702662133
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.9779814702662133
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.9779814702662133
TRACHEOBRONCHOMEGALY	0.0196078	0.9779814702662133
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.9779814702662133
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.9779814702662133
CARPAL DISPLACEMENT	0.0196078	0.9779814702662133
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.9779814702662133
THROMBOCYTOPENIA 3	0.0196078	0.9779814702662133
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.01948565	0.9718889745964788
15q26 overgrowth syndrome	0.01948565	0.9718889745964788
DESANTO-SHINAWI SYNDROME	0.019430382	0.9691323634571019
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.019430382	0.9691323634571019
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.019430382	0.9691323634571019
TONNE-KALSCHEUER SYNDROME; TOKAS	0.019068592000000002	0.951087304035463
LOWRY-MACLEAN SYNDROME	0.019068592000000002	0.951087304035463
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.019007029999999998	0.9480167660213802
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.019007029999999998	0.9480167660213802
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.019007029999999998	0.9480167660213802
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.9410773560948135
DIASTEMATOMYELIA	0.0188679	0.9410773560948135
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.9410773560948135
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.9410773560948135
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.9410773560948135
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.9410773560948135
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.9410773560948135
RHEUMATOID ARTHRITIS	0.0188679	0.9410773560948135
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.9410773560948135
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.9410773560948135
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.9410773560948135
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.9410773560948135
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.9410773560948135
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.9410773560948135
CARDIAC ARRHYTHMIA	0.0188679	0.9410773560948135
ALCOHOL DEPENDENCE	0.0188679	0.9410773560948135
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.9410773560948135
PALMOMENTAL REFLEX	0.0188679	0.9410773560948135
CERVICAL RIB	0.0188679	0.9410773560948135
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.9410773560948135
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.9410773560948135
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.9410773560948135
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.9410773560948135
MOTION SICKNESS	0.0188679	0.9410773560948135
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.9410773560948135
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.9410773560948135
TRANSSEXUALITY	0.0188679	0.9410773560948135
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.9410773560948135
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.9410773560948135
JUMPING FRENCHMAN OF MAINE	0.0188679	0.9410773560948135
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.9410773560948135
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.9410773560948135
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.9410773560948135
MYOPATHY, CONGENITAL	0.0188679	0.9410773560948135
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.9410773560948135
269800 SENILE PLAQUE FORMATION	0.0188679	0.9410773560948135
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.9410773560948135
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.9410773560948135
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01881941	0.9386588123778637
OCULODENTODIGITAL DYSPLASIA; ODDD	0.018775850000000004	0.9364861630829507
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.018708702	0.9331370112267793
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01859069	0.9272509072646287
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.01851691	0.9235709700520786
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.01851691	0.9235709700520786
COHEN SYNDROME	0.01851691	0.9235709700520786
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.01851691	0.9235709700520786
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01851691	0.9235709700520786
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.01851691	0.9235709700520786
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.01851691	0.9235709700520786
TARP SYNDROME; TARPS	0.018387782000000002	0.9171304315269746
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.018387782000000002	0.9171304315269746
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.018344222000000004	0.9149577822320615
COHEN-GIBSON SYNDROME; COGIS	0.018304602	0.9129816489661189
Miller-Dieker syndrome (MDS)	0.01822471	0.908996862522841
OROFACIODIGITAL SYNDROME I; OFD1	0.01822471	0.908996862522841
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.01822471	0.908996862522841
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01822471	0.908996862522841
9q subtelomeric deletion syndrome	0.01822471	0.908996862522841
ALLAN-HERNDON-DUDLEY SYNDROME	0.018142659999999998	0.9049044411581112
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01811011	0.9032809394466921
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.01811011	0.9032809394466921
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.018085282	0.9020425892011894
SEPTOOPTIC DYSPLASIA	0.018085282	0.9020425892011894
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.018085282	0.9020425892011894
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.018085282	0.9020425892011894
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.018085282	0.9020425892011894
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01783664	0.8896410312125352
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.017793082	0.8874684816719517
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.017793082	0.8874684816719517
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.017793082	0.8874684816719517
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.017649802000000003	0.8803220815118245
ASPARTYLGLUCOSAMINURIA; AGU	0.0175758	0.8766310715687078
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0175439	0.8750399900143523
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0175439	0.8750399900143523
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0175439	0.8750399900143523
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.0175439	0.8750399900143523
BARAITSER-WINTER SYNDROME 2; BRWS2	0.0175439	0.8750399900143523
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.0175439	0.8750399900143523
OHDO SYNDROME	0.0175439	0.8750399900143523
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.0175439	0.8750399900143523
AUROCEPHALOSYNDACTYLY	0.0175439	0.8750399900143523
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.017500340000000003	0.8728673407194394
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0172414	0.8599521476885672
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.0172414	0.8599521476885672
Oliver-McFarlane syndrome	0.0172414	0.8599521476885672
#173100 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2;;IGHD II;;GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL DOMINANT;;PITUITARY DWARFISM DUE TO ISOLATED GROWTH HORMONE DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.8599521476885672
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0172414	0.8599521476885672
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0172414	0.8599521476885672
#245590 GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;;LARON SYNDROME DUE TO POSTRECEPTOR DEFECT;;GROWTH HORMONE INSENSITIVITY DUE TO POSTRECEPTOR DEFECT	0.0172414	0.8599521476885672
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0172414	0.8599521476885672
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0172414	0.8599521476885672
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.0172414	0.8599521476885672
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0172414	0.8599521476885672
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0172414	0.8599521476885672
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.0172414	0.8599521476885672
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0172414	0.8599521476885672
LIG4 SYNDROME	0.017044792	0.850145898088607
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.017044792	0.850145898088607
TOWNES-BROCKS SYNDROME 1; TBS1	0.017044792	0.850145898088607
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.017044792	0.850145898088607
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.017044792	0.850145898088607
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.0169492	0.8453780401593294
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.0169492	0.8453780401593294
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.0169492	0.8453780401593294
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0169492	0.8453780401593294
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0169492	0.8453780401593294
Cat-Eye Syndrome (Type I)	0.0169492	0.8453780401593294
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.0169492	0.8453780401593294
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0169492	0.8453780401593294
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.0169492	0.8453780401593294
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.016881642000000002	0.8420084386656259
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.016771322	0.8365059898544502
HURLER-SCHEIE SYNDROME	0.01662076	0.8289963841808803
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01662076	0.8289963841808803
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.01642733	0.8193486442103791
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.016406842	0.8183267608597323
WIEACKER-WOLFF SYNDROME	0.016406842	0.8183267608597323
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.016406842	0.8183267608597323
OGDEN SYNDROME; OGDNS	0.016307982000000002	0.8133959043561716
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.016275432	0.8117724026447523
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.01620091	0.8080554565759848
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.01620091	0.8080554565759848
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.01620091	0.8080554565759848
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.016102012000000002	0.803122704740165
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.016076722	0.8018613112445647
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.01603776	0.7999179971530036
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.016005210000000002	0.7982944954415846
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.015606132000000002	0.7783896163021145
POLYCYSTIC OVARY SYNDROME 1	0.015575929999999998	0.776883226173442
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01556296	0.77623631934711
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.014939892000000003	0.7451594540834994
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.014925399999999998	0.7444366342124734
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.014925399999999998	0.7444366342124734
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.014925399999999998	0.7444366342124734
#612885 PREMATURE OVARIAN FAILURE 10; POF10MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED;MENOQ3, INCLUDED	0.014925399999999998	0.7444366342124734
MYXEDEMA	0.014925399999999998	0.7444366342124734
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.014925399999999998	0.7444366342124734
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.014925399999999998	0.7444366342124734
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.014925399999999998	0.7444366342124734
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.014925399999999998	0.7444366342124734
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.014925399999999998	0.7444366342124734
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.014925399999999998	0.7444366342124734
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.014925399999999998	0.7444366342124734
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.014925399999999998	0.7444366342124734
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.014925399999999998	0.7444366342124734
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.014925399999999998	0.7444366342124734
TUBEROUS SCLEROSIS	0.014925399999999998	0.7444366342124734
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.014925399999999998	0.7444366342124734
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.014925399999999998	0.7444366342124734
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.014925399999999998	0.7444366342124734
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.014925399999999998	0.7444366342124734
PRECOCIOUS PUBERTY, CENTRAL	0.014925399999999998	0.7444366342124734
TUBEROUS SCLEROSIS 2; TSC2	0.014925399999999998	0.7444366342124734
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.014925399999999998	0.7444366342124734
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.014925399999999998	0.7444366342124734
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.014925399999999998	0.7444366342124734
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.014925399999999998	0.7444366342124734
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.014925399999999998	0.7444366342124734
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.014829572000000001	0.7396570052723237
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.014762250000000001	0.7362991747894923
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.014762250000000001	0.7362991747894923
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.014762250000000001	0.7362991747894923
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.014762250000000001	0.7362991747894923
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.014762250000000001	0.7362991747894923
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.014762250000000001	0.7362991747894923
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.014762250000000001	0.7362991747894923
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.014762250000000001	0.7362991747894923
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.014762250000000001	0.7362991747894923
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.014762250000000001	0.7362991747894923
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.014762250000000001	0.7362991747894923
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.014762250000000001	0.7362991747894923
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.01467901	0.7321473995987539
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01467901	0.7321473995987539
Lipodystrophy, congenital generalized, type 2	0.01467901	0.7321473995987539
Lipodystrophy, congenital generalized, type 1	0.01467901	0.7321473995987539
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.014465092000000002	0.7214777762776059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.014465092000000002	0.7214777762776059
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.014465092000000002	0.7214777762776059
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.014465092000000002	0.7214777762776059
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.014391089999999999	0.7177867663344891
COCKAYNE SYNDROME A; CSA	0.01436121	0.7162964366528546
Ullrich congenital muscular dystrophy 1	0.01428745	0.7126174969835988
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.01428745	0.7126174969835988
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.01428745	0.7126174969835988
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.01428745	0.7126174969835988
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.014279931999999999	0.7122425204592837
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.014096010000000003	0.7030690125708772
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.014096010000000003	0.7030690125708772
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.013982620000000001	0.6974134408640316
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.013982620000000001	0.6974134408640316
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.01395733	0.6961520473684312
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.013929582000000001	0.6947680558019655
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.013664382000000003	0.681540631719988
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.013664382000000003	0.681540631719988
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.013664382000000003	0.681540631719988
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.013664382000000003	0.681540631719988
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.013664382000000003	0.681540631719988
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.013664382000000003	0.681540631719988
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013664382000000003	0.681540631719988
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.013664382000000003	0.681540631719988
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.013664382000000003	0.681540631719988
RHIZOMELIC SYNDROME	0.013621210000000002	0.6793873347649837
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.013621210000000002	0.6793873347649837
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.013613692	0.6790123582406687
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.013613692	0.6790123582406687
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.013613692	0.6790123582406687
CHROMOSOME 9P DELETION SYNDROME	0.013558252	0.6762471682289611
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.013558252	0.6762471682289611
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.013558252	0.6762471682289611
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.013558252	0.6762471682289611
#307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2;;CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;;CGH;;HCG	0.013436049999999998	0.6701520789466616
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.013293222	0.6630282232649849
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.013189582000000002	0.6578589539140944
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.013189582000000002	0.6578589539140944
3MC SYNDROME 2	0.013189582000000002	0.6578589539140944
TEMTAMY SYNDROME; TEMTYS	0.013189582000000002	0.6578589539140944
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.013189582000000002	0.6578589539140944
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.013118250000000001	0.6543011160007626
COFFIN-SIRIS SYNDROME 6; CSS6	0.013090722	0.6529280974105337
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.0130857	0.6526776142893433
Mental retardation, autosomal dominant 21	0.012892012000000001	0.6430170060103461
TURNPENNY-FRY SYNDROME; TPFS	0.012892012000000001	0.6430170060103461
%300712 CRANIOFACIOSKELETAL SYNDROME	0.012892012000000001	0.6430170060103461
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.012892012000000001	0.6430170060103461
OROFACIODIGITAL SYNDROME XIV; OFD14	0.012892012000000001	0.6430170060103461
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.012892012000000001	0.6430170060103461
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.012892012	0.6430170060103461
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.012820500000000002	0.6394501902073658
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.012820500000000002	0.6394501902073658
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.012820500000000002	0.6394501902073658
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.012820500000000002	0.6394501902073658
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.012820500000000002	0.6394501902073658
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.012820500000000002	0.6394501902073658
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.012820500000000002	0.6394501902073658
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.012820500000000002	0.6394501902073658
#602433 AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES	0.012820500000000002	0.6394501902073658
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.012820500000000002	0.6394501902073658
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.012820500000000002	0.6394501902073658
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.012820500000000002	0.6394501902073658
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.012820500000000002	0.6394501902073658
IMMUNODEFICIENCY 9; IMD9	0.012820500000000002	0.6394501902073658
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.012820500000000002	0.6394501902073658
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.012820500000000002	0.6394501902073658
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.012820500000000002	0.6394501902073658
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.012820500000000002	0.6394501902073658
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.012820500000000002	0.6394501902073658
NEMALINE MYOPATHY 4	0.012820500000000002	0.6394501902073658
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.012820500000000002	0.6394501902073658
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.012820500000000002	0.6394501902073658
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.012820500000000002	0.6394501902073658
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.012820500000000002	0.6394501902073658
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.012820500000000002	0.6394501902073658
#613376 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C;;HMN IIC;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC;;DHMN2C	0.012820500000000002	0.6394501902073658
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.012820500000000002	0.6394501902073658
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.012820500000000002	0.6394501902073658
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.012820500000000002	0.6394501902073658
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.012820500000000002	0.6394501902073658
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.012820500000000002	0.6394501902073658
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.012820500000000002	0.6394501902073658
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.012820500000000002	0.6394501902073658
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.012820500000000002	0.6394501902073658
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.012820500000000002	0.6394501902073658
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.012820500000000002	0.6394501902073658
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.012820500000000002	0.6394501902073658
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.012820500000000002	0.6394501902073658
#615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	0.012820500000000002	0.6394501902073658
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.01276981	0.6369219167280465
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.01276981	0.6369219167280465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.01276981	0.6369219167280465
ACHALASIA-MICROCEPHALY SYNDROME	0.01276981	0.6369219167280465
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.01271437	0.6341567267163389
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.01271437	0.6341567267163389
MARSHALL-SMITH SYNDROME; MRSHSS	0.01271437	0.6341567267163389
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.01271018	0.6339477413961901
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.01271018	0.6339477413961901
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01271018	0.6339477413961901
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.012686622000000002	0.6327727351498734
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.012686622000000002	0.6327727351498734
HYPERMANGANESEMIA WITH DYSTONIA 2	0.012686622000000002	0.6327727351498734
Glycosylphosphatidylinositol biosynthesis defect 18	0.012396302000000001	0.6182923966902967
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.012345700000000001	0.6157685124014723
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.012345700000000001	0.6157685124014723
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.012345700000000001	0.6157685124014723
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.012345700000000001	0.6157685124014723
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.012345700000000001	0.6157685124014723
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.012345700000000001	0.6157685124014723
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.012345700000000001	0.6157685124014723
HYPEREKPLEXIA 1; HKPX1	0.012345700000000001	0.6157685124014723
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.012345700000000001	0.6157685124014723
COXOAURICULAR SYNDROME	0.012345700000000001	0.6157685124014723
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.012345700000000001	0.6157685124014723
BETHLEM MYOPATHY 2; BTHLM2	0.012345700000000001	0.6157685124014723
DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION	0.012345700000000001	0.6157685124014723
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.012345700000000001	0.6157685124014723
LUSCAN-LUMISH SYNDROME; LLS	0.012338182	0.6153935358771573
CURRY-JONES SYNDROME	0.012338182	0.6153935358771573
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.012338182	0.6153935358771573
JOUBERT SYNDROME 10	0.012338182	0.6153935358771573
IMMUNODEFICIENCY 49; IMD49	0.012338182	0.6153935358771573
BARDET-BIEDL SYNDROME 1; BBS1	0.012338182	0.6153935358771573
FRYNS SYNDROME; FRNS	0.01224684	0.6108376558979115
SIFRIM-HITZ-WEISS SYNDROME	0.01224684	0.6108376558979115
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.01224684	0.6108376558979115
MORQUIO SYNDROME A	0.01221866	0.6094321173962896
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.01221866	0.6094321173962896
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.01221866	0.6094321173962896
Myhre syndrome	0.01204813	0.600926564497724
3MC SYNDROME 1	0.01204813	0.600926564497724
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.01204813	0.600926564497724
ROBERTS SYNDROME; RBS	0.01204813	0.600926564497724
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.012020382000000001	0.5995425729312582
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.011842740000000001	0.5906822936372512
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.011842740000000001	0.5906822936372512
TENORIO SYNDROME; TNORS	0.011842740000000001	0.5906822936372512
MYOPATHY, DISTAL, 1; MPD1	0.011842740000000001	0.5906822936372512
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.011616502	0.5793981836468348
#614976 CARPENTER SYNDROME 2; CRPT2	0.011616502	0.5793981836468348
NOONAN SYNDROME 3; NS3	0.011616502	0.5793981836468348
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.011616502	0.5793981836468348
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.011494299999999999	0.5733030943645352
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.011494299999999999	0.5733030943645352
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.011494299999999999	0.5733030943645352
CARNEY COMPLEX, TYPE 1; CNC1	0.011494299999999999	0.5733030943645352
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.011494299999999999	0.5733030943645352
BENT BONE DYSPLASIA SYNDROME; BBDS	0.011494299999999999	0.5733030943645352
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.011494299999999999	0.5733030943645352
46,XY SEX REVERSAL 6; SRXY6	0.011494299999999999	0.5733030943645352
LICHTENSTEIN SYNDROME	0.011494299999999999	0.5733030943645352
OVARIAN DYSGENESIS 2; ODG2	0.011494299999999999	0.5733030943645352
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.011494299999999999	0.5733030943645352
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.011494299999999999	0.5733030943645352
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.011494299999999999	0.5733030943645352
#158330 MULLERIAN APLASIA AND HYPERANDROGENISM;;MULLERIAN DUCT FAILURE AND HYPERANDROGENISM	0.011494299999999999	0.5733030943645352
CRANIORHINY	0.011494299999999999	0.5733030943645352
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.011494299999999999	0.5733030943645352
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.011494299999999999	0.5733030943645352
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.011494299999999999	0.5733030943645352
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.011494299999999999	0.5733030943645352
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.011494299999999999	0.5733030943645352
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0111765	0.557452131418636
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0111765	0.557452131418636
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0111765	0.557452131418636
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0111765	0.557452131418636
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.0111765	0.557452131418636
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.011153342	0.5562970760382046
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.011120792000000001	0.5546735743267853
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.01077262	0.5373077421342126
#614432 VENTRICULAR SEPTAL DEFECT 3; VSD3	0.01077262	0.5373077421342126
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.01077262	0.5373077421342126
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.01077262	0.5373077421342126
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.01077262	0.5373077421342126
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.01077262	0.5373077421342126
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.01077262	0.5373077421342126
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.01077262	0.5373077421342126
CARDIAC-UROGENITAL SYNDROME; CUGS	0.01077262	0.5373077421342126
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.01077262	0.5373077421342126
NOONAN SYNDROME 8; NS8	0.01077262	0.5373077421342126
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.01077262	0.5373077421342126
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.01077262	0.5373077421342126
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.01077262	0.5373077421342126
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01077262	0.5373077421342126
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.010744872	0.5359237505677469
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.010744872	0.5359237505677469
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.010744872	0.5359237505677469
JOUBERT SYNDROME 24	0.010744872	0.5359237505677469
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.010744872	0.5359237505677469
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010744872	0.5359237505677469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.010744872	0.5359237505677469
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.010744872	0.5359237505677469
HYDROCEPHALUS, NORMAL-PRESSURE	0.010744872	0.5359237505677469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.010744872	0.5359237505677469
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.010744872	0.5359237505677469
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.010511780000000002	0.5242977824903853
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.01030946	0.5142066345255824
COFFIN-LOWRY SYNDROME; CLS	0.01030946	0.5142066345255824
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01030946	0.5142066345255824
NEURAMINIDASE DEFICIENCY	0.01027691	0.5125831328141632
MUCOPOLYSACCHARIDOSIS, TYPE II	0.01027691	0.5125831328141632
BECKWITH-WIEDEMANN SYNDROME	0.01027691	0.5125831328141632
PSEUDO-TORCH SYNDROME 2	0.010078199999999999	0.5026720414139755
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.4938333090551247
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.4938333090551247
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.4938333090551247
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00990099	0.4938333090551247
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.4938333090551247
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.4938333090551247
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.4938333090551247
METACHROMATIC LEUKODYSTROPHY	0.00990099	0.4938333090551247
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.4938333090551247
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.4938333090551247
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00990099	0.4938333090551247
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00990099	0.4938333090551247
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00990099	0.4938333090551247
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.4938333090551247
DYSTONIA 23; DYT23	0.00990099	0.4938333090551247
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.4938333090551247
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00990099	0.4938333090551247
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00990099	0.4938333090551247
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.4938333090551247
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00990099	0.4938333090551247
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00990099	0.4938333090551247
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.4938333090551247
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00990099	0.4938333090551247
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00990099	0.4938333090551247
MYOCLONIC EPILEPSY OF LAFORA	0.00990099	0.4938333090551247
ALZHEIMER DISEASE 3; AD	0.00990099	0.4938333090551247
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00990099	0.4938333090551247
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.4938333090551247
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00990099	0.4938333090551247
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00990099	0.4938333090551247
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00990099	0.4938333090551247
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.4938333090551247
BRITTLE CORNEA SYNDROME 2; BCS2	0.00990099	0.4938333090551247
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.4938333090551247
NEMALINE MYOPATHY 7; NEM7	0.00990099	0.4938333090551247
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.4938333090551247
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00990099	0.4938333090551247
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.4938333090551247
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00990099	0.4938333090551247
NEMALINE MYOPATHY 6	0.00990099	0.4938333090551247
MAST SYNDROME	0.00990099	0.4938333090551247
BEHR SYNDROME	0.00990099	0.4938333090551247
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00990099	0.4938333090551247
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00990099	0.4938333090551247
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.4938333090551247
NONAKA MYOPATHY	0.00990099	0.4938333090551247
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.00990099	0.4938333090551247
DYSTONIA 16; DYT16	0.00990099	0.4938333090551247
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.4938333090551247
KUFOR-RAKEB SYNDROME	0.00990099	0.4938333090551247
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00990099	0.4938333090551247
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00990099	0.4938333090551247
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.009877832	0.4926782536746932
RAYNAUD-CLAES SYNDROME; MRXSRC	0.009877832	0.4926782536746932
SCHAAF-YANG SYNDROME; SHFYNG	0.009877832	0.4926782536746932
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.009877832	0.4926782536746932
PETTIGREW SYNDROME	0.009877832	0.4926782536746932
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.009236270000000001	0.46067896012687387
%608572 BURN-MCKEOWN SYNDROME	0.009236270000000001	0.46067896012687387
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.009215782	0.45965707677622697
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009215782	0.45965707677622697
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.009211592000000001	0.4594480914560781
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.009211592000000001	0.4594480914560781
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009211592000000001	0.4594480914560781
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.009211592000000001	0.4594480914560781
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.009211592000000001	0.4594480914560781
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009211592000000001	0.4594480914560781
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.009211592000000001	0.4594480914560781
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.009211592000000001	0.4594480914560781
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.009211592000000001	0.4594480914560781
GAPO SYNDROME; GAPOS	0.009208089999999999	0.45927342162525187
BASAL CELL NEVUS SYNDROME	0.009033949999999999	0.45058781216207094
MUCOLIPIDOSIS III GAMMA	0.009033949999999999	0.45058781216207094
CLARK-BARAITSER SYNDROME	0.009033949999999999	0.45058781216207094
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.009033949999999999	0.45058781216207094
MUCOLIPIDOSIS III ALPHA/BETA	0.009033949999999999	0.45058781216207094
FRAGILE X MENTAL RETARDATION SYNDROME	0.009033949999999999	0.45058781216207094
ATKIN-FLAITZ SYNDROME	0.009033949999999999	0.45058781216207094
MACS SYNDROME	0.009033949999999999	0.45058781216207094
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00880269	0.43905321905046424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00880269	0.43905321905046424
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.008403612	0.41914833991099415
MIRAGE SYNDROME; MIRAGE	0.008403612	0.41914833991099415
RENPENNING SYNDROME 1; RENS1	0.008371900000000002	0.4175666352636049
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00836771	0.41735764994345587
KLEEFSTRA SYNDROME	0.00836771	0.41735764994345587
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00836771	0.41735764994345587
PITT-HOPKINS SYNDROME	0.00836771	0.41735764994345587
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.008110222	0.4045148785557476
MEIER-GORLIN SYNDROME 7	0.007940272	0.39603825441271556
SHASHI-PENA SYNDROME; SHAPNS	0.007940272	0.39603825441271556
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.007940272	0.39603825441271556
CHROMOSOME 2q37 DELETION SYNDROME	0.007936082	0.3958292690925667
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.007936082	0.3958292690925667
MENTAL RETARDATION, X-LINKED 103	0.007936082	0.3958292690925667
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.007936082	0.3958292690925667
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.007936082	0.3958292690925667
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.007936082	0.3958292690925667
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.007936082	0.3958292690925667
SHUKLA-VERNON SYNDROME; SHUVER	0.007936082	0.3958292690925667
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.007737372	0.38591817769237907
PHELAN-MCDERMID SYNDROME; PHMDS	0.007737372	0.38591817769237907
#602398 DESMOSTEROLOSIS	0.007737372	0.38591817769237907
MICROPHTHALMIA, SYNDROMIC 3	0.007737372	0.38591817769237907
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00755973	0.37705789839837206
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00755973	0.37705789839837206
LATERAL MENINGOCELE SYNDROME	0.00755973	0.37705789839837206
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.00755973	0.37705789839837206
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00755973	0.37705789839837206
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00755973	0.37705789839837206
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00755973	0.37705789839837206
HUNTER-MACDONALD SYNDROME	0.00755973	0.37705789839837206
LOEYS-DIETZ SYNDROME 3; LDS3	0.00755973	0.37705789839837206
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.007298890000000001	0.3640479387545447
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.007274032000000001	0.3628080921941005
AL KAISSI SYNDROME; ALKAS	0.007274032000000001	0.3628080921941005
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.007274032000000001	0.3628080921941005
ADAMS-OLIVER SYNDROME 1; AOS1	0.007274032000000001	0.3628080921941005
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.007274032000000001	0.3628080921941005
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.007274032000000001	0.3628080921941005
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.007274032000000001	0.3628080921941005
SECKEL SYNDROME 9; SCKL9	0.007274032000000001	0.3628080921941005
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00726634	0.36242443704312544
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.007245852	0.36140255369247853
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00709639	0.3539478129000935
DUANE-RADIAL RAY SYNDROME; DRRS	0.00709639	0.3539478129000935
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00709639	0.3539478129000935
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0070922	0.35373882757994457
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0070922	0.35373882757994457
268650 RUDIGER SYNDROME	0.0070922	0.35373882757994457
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.0070922	0.35373882757994457
#277950 WINCHESTER SYNDROME; WNCHRS	0.0070922	0.35373882757994457
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0070922	0.35373882757994457
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.0070922	0.35373882757994457
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0070922	0.35373882757994457
FOUNTAIN SYNDROME	0.0070922	0.35373882757994457
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0070922	0.35373882757994457
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.0070922	0.35373882757994457
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.0070922	0.35373882757994457
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.0070922	0.35373882757994457
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0070922	0.35373882757994457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0070922	0.35373882757994457
SANDHOFF DISEASE	0.0070922	0.35373882757994457
#151210 PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT;;LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, TORRANCE TYPE;;THANATOPHORIC DYSPLASIA, TORRANCE VARIANTPLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, LUTON TYPE, INCLUDED; PLSDL,INCLUDED;;THANATOPHORIC DYSPLASIA, LUTON VARIANT, INCLUDED	0.0070922	0.35373882757994457
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.0070922	0.35373882757994457
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00689349	0.3438277361797569
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00689349	0.3438277361797569
FEINGOLD SYNDROME 1; FGLDS1	0.00689349	0.3438277361797569
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00689349	0.3438277361797569
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00689349	0.3438277361797569
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00689349	0.3438277361797569
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.006461862	0.3222993553288677
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.006461862	0.3222993553288677
CHAR SYNDROME	0.006461862	0.3222993553288677
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.006461862	0.3222993553288677
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006461862	0.3222993553288677
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.006430150000000001	0.3207176506814784
JACOBSEN SYNDROME	0.006430150000000001	0.3207176506814784
PSEUDOTRISOMY 13 SYNDROME	0.006430150000000001	0.3207176506814784
MENTAL RETARDATION, BUENOS AIRES TYPE	0.006430150000000001	0.3207176506814784
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.006430150000000001	0.3207176506814784
MECKEL SYNDROME, TYPE 4; MKS4	0.006430150000000001	0.3207176506814784
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0062010220000000005	0.3092893956850403
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00602338	0.3004291163910333
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00602338	0.3004291163910333
CHROMOSOME 15Q14 DELETION SYNDROME	0.005998522	0.29918926983058913
NOONAN SYNDROME 5; NS5	0.005998522	0.29918926983058913
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.005998522	0.29918926983058913
NOONAN SYNDROME 11; NS11	0.005998522	0.29918926983058913
OROTIC ACIDURIA	0.005998522	0.29918926983058913
FRONTOOCULAR SYNDROME	0.005998522	0.29918926983058913
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005998522	0.29918926983058913
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.005998522	0.29918926983058913
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.005998522	0.29918926983058913
Bardet-Biedl syndrome 2	0.005998522	0.29918926983058913
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.005998522	0.29918926983058913
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.005998522	0.29918926983058913
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.005998522	0.29918926983058913
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.005970342	0.2977837313289672
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00561798	0.2802089138162456
PATENT DUCTUS ARTERIOSUS 2	0.00561798	0.2802089138162456
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.00561798	0.2802089138162456
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00561798	0.2802089138162456
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00561798	0.2802089138162456
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00561798	0.2802089138162456
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00561798	0.2802089138162456
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.00561798	0.2802089138162456
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00561798	0.2802089138162456
PATENT DUCTUS ARTERIOSUS 1	0.00561798	0.2802089138162456
HEMIFACIAL MICROSOMIA	0.00561798	0.2802089138162456
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00561798	0.2802089138162456
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00561798	0.2802089138162456
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00561798	0.2802089138162456
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.00561798	0.2802089138162456
DIAMOND-BLACKFAN ANEMIA 10	0.00561798	0.2802089138162456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00561798	0.2802089138162456
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.00561798	0.2802089138162456
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00561798	0.2802089138162456
THORACOABDOMINAL SYNDROME	0.00561798	0.2802089138162456
HOLT-ORAM SYNDROME	0.00561798	0.2802089138162456
PATENT DUCTUS ARTERIOSUS 3	0.00561798	0.2802089138162456
CAYLER CARDIOFACIAL SYNDROME	0.00561798	0.2802089138162456
LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	0.00561798	0.2802089138162456
XYLOSIDASE DEFICIENCY	0.00535714	0.2671989541724182
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00535714	0.2671989541724182
CARDIAC LIPIDOSIS, FAMILIAL	0.00535714	0.2671989541724182
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00535714	0.2671989541724182
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00535714	0.2671989541724182
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00535714	0.2671989541724182
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00535714	0.2671989541724182
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.005304102	0.2645535691103521
INFANTILE LIVER FAILURE SYNDROME 1	0.005304102	0.2645535691103521
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005304102	0.2645535691103521
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.005304102	0.2645535691103521
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.005304102	0.2645535691103521
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.005304102	0.2645535691103521
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.005304102	0.2645535691103521
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.005304102	0.2645535691103521
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.005304102	0.2645535691103521
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.005304102	0.2645535691103521
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.005304102	0.2645535691103521
AICARDI-GOUTIERES SYNDROME 7	0.005304102	0.2645535691103521
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.00515464	0.257098828317967
MCDONOUGH SYNDROME	0.00515464	0.257098828317967
LYMPHATIC MALFORMATION 7; LMPHM7	0.00515464	0.257098828317967
ATRIAL SEPTAL DEFECT 5	0.00515464	0.257098828317967
8p23.1 deletion syndrome	0.00515464	0.257098828317967
ELLIS-VAN CREVELD SYNDROME	0.00515464	0.257098828317967
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.00515464	0.257098828317967
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.00515464	0.257098828317967
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00515464	0.257098828317967
#614433 ATRIAL SEPTAL DEFECT 8; ASD8	0.00515464	0.257098828317967
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00515464	0.257098828317967
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00515464	0.257098828317967
#614429 VENTRICULAR SEPTAL DEFECT 1; VSD1	0.00515464	0.257098828317967
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00515464	0.257098828317967
DIAMOND-BLACKFAN ANEMIA 16	0.00515464	0.257098828317967
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00515464	0.257098828317967
#613087 ATRIAL SEPTAL DEFECT 6; ASD6	0.00515464	0.257098828317967
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00515464	0.257098828317967
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00515464	0.257098828317967
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00515464	0.257098828317967
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00515464	0.257098828317967
ALAGILLE SYNDROME 2	0.00515464	0.257098828317967
AORTIC VALVE DISEASE 3; AOVD3	0.00515464	0.257098828317967
EBSTEIN ANOMALY	0.00515464	0.257098828317967
#607941 ATRIAL SEPTAL DEFECT 2; ASD2	0.00515464	0.257098828317967
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00515464	0.257098828317967
HYPERTELORISM, TEEBI TYPE; TBHS	0.00515464	0.257098828317967
#614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITHOR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY	0.00515464	0.257098828317967
ALAGILLE SYNDROME 1; ALGS1	0.00515464	0.257098828317967
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.00515464	0.257098828317967
DIAMOND-BLACKFAN ANEMIA 4	0.00515464	0.257098828317967
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00515464	0.257098828317967
WHITE FORELOCK WITH MALFORMATIONS	0.00515464	0.257098828317967
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00515464	0.257098828317967
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.005126459999999999	0.25569328981634504
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.005126459999999999	0.25569328981634504
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.005126459999999999	0.25569328981634504
REVESZ SYNDROME	0.004925512	0.24567057332152897
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004925512	0.24567057332152897
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004925512	0.24567057332152897
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.24567057332152897
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004925512	0.24567057332152897
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.004925512	0.24567057332152897
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004925512	0.24567057332152897
SALLA DISEASE	0.004925512	0.24567057332152897
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004925512	0.24567057332152897
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004925512	0.24567057332152897
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00446022	0.22246312759772996
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00446022	0.22246312759772996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00446022	0.22246312759772996
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.00446022	0.22246312759772996
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00446022	0.22246312759772996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00446022	0.22246312759772996
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00446022	0.22246312759772996
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.20358013180890683
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.20358013180890683
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.20358013180890683
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.20358013180890683
BEETURIA	0.00408163	0.20358013180890683
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.20358013180890683
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.20358013180890683
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.20358013180890683
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.20358013180890683
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.20358013180890683
CITRULLINE TRANSPORT DEFECT	0.00408163	0.20358013180890683
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.20358013180890683
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.20358013180890683
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.20358013180890683
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.20358013180890683
XANTHINURIA, TYPE I	0.00408163	0.20358013180890683
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.20358013180890683
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.20358013180890683
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.20358013180890683
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.20358013180890683
LYMPHOKINE DEFICIENCY	0.00408163	0.20358013180890683
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.20358013180890683
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.20358013180890683
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.20358013180890683
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.20358013180890683
HYPOASCORBEMIA	0.00408163	0.20358013180890683
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00408163	0.20358013180890683
PITUITARY DWARFISM IV	0.00408163	0.20358013180890683
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.20358013180890683
ETHANOLAMINOSIS	0.00408163	0.20358013180890683
GLUTATHIONURIA	0.00408163	0.20358013180890683
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.20358013180890683
MACROCYTOSIS, FAMILIAL	0.00408163	0.20358013180890683
EPILEPSY-TELANGIECTASIA	0.00408163	0.20358013180890683
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.20358013180890683
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.20358013180890683
PERRY SYNDROME	0.00408163	0.20358013180890683
HEINZ BODY ANEMIAS	0.00408163	0.20358013180890683
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00408163	0.20358013180890683
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.20358013180890683
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.20358013180890683
HOOFT DISEASE	0.00408163	0.20358013180890683
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.20358013180890683
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.20358013180890683
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.20358013180890683
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.20358013180890683
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.20358013180890683
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.20358013180890683
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.20358013180890683
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.20358013180890683
ACETYLATION, SLOW	0.00408163	0.20358013180890683
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.20358013180890683
PROGESTERONE RESISTANCE	0.00408163	0.20358013180890683
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.20358013180890683
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.20358013180890683
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.20358013180890683
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.20358013180890683
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.20358013180890683
OVARIAN CANCER	0.00408163	0.20358013180890683
XM SYSTEM	0.00408163	0.20358013180890683
ICHTHYOSIS AND MALE HYPOGONADISM	0.00408163	0.20358013180890683
PACMAN DYSPLASIA	0.00408163	0.20358013180890683
ZINC, ELEVATED PLASMA	0.00408163	0.20358013180890683
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.20358013180890683
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.20358013180890683
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.20358013180890683
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.20358013180890683
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.20358013180890683
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.20358013180890683
COUMARIN RESISTANCE	0.00408163	0.20358013180890683
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.20358013180890683
HYPERPROGLUCAGONEMIA	0.00408163	0.20358013180890683
ONCOCYTOMA	0.00408163	0.20358013180890683
DERMATITIS, ATOPIC	0.00408163	0.20358013180890683
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.20358013180890683
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.20358013180890683
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.20358013180890683
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.20358013180890683
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.20358013180890683
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.20358013180890683
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.20358013180890683
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.20358013180890683
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.20358013180890683
OSTEOGENIC SARCOMA	0.00408163	0.20358013180890683
CEPHALIN LIPIDOSIS	0.00408163	0.20358013180890683
GLUTATHIONE REDUCTASE	0.00408163	0.20358013180890683
HYPERLEUCINE-ISOLEUCINEMIA	0.00408163	0.20358013180890683
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.20358013180890683
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.20358013180890683
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.20358013180890683
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.20358013180890683
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.20358013180890683
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.20358013180890683
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.20358013180890683
MYOPATHY, SPHEROID BODY	0.00408163	0.20358013180890683
PARAOXONASE 1	0.00408163	0.20358013180890683
GLOMUVENOUS MALFORMATIONS	0.00408163	0.20358013180890683
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.20358013180890683
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.20358013180890683
ALAND ISLAND EYE DISEASE	0.00408163	0.20358013180890683
CALVARIAL HYPEROSTOSIS	0.00408163	0.20358013180890683
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.20358013180890683
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00408163	0.20358013180890683
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.20358013180890683
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.20358013180890683
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.20358013180890683
DERMATOLEUKODYSTROPHY	0.00408163	0.20358013180890683
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.20358013180890683
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.20358013180890683
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.20358013180890683
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.20358013180890683
FLOOD FACTOR DEFICIENCY	0.00408163	0.20358013180890683
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.20358013180890683
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.20358013180890683
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.20358013180890683
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.20358013180890683
AREDYLD	0.00408163	0.20358013180890683
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.20358013180890683
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.20358013180890683
DELETED IN AZOOSPERMIA	0.00408163	0.20358013180890683
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.20358013180890683
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.20358013180890683
SCHIZOPHRENIA 4	0.00408163	0.20358013180890683
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.20358013180890683
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.20358013180890683
T-SUBSTANCE ANOMALY	0.00408163	0.20358013180890683
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.20358013180890683
ICHTHYOSIS, X-LINKED	0.00408163	0.20358013180890683
CARBOXYLESTERASE 1	0.00408163	0.20358013180890683
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.20358013180890683
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.20358013180890683
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.00408163	0.20358013180890683
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.20358013180890683
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.20358013180890683
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.20358013180890683
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.20358013180890683
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.20358013180890683
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.20358013180890683
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.20358013180890683
PREMATURE OVARIAN FAILURE 1	0.00408163	0.20358013180890683
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.20358013180890683
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.20358013180890683
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.20358013180890683
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.20358013180890683
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.20358013180890683
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.20358013180890683
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.20358013180890683
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.20358013180890683
FINGERPRINT BODY MYOPATHY	0.00408163	0.20358013180890683
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.20358013180890683
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.20358013180890683
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.20358013180890683
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.20358013180890683
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.20358013180890683
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.20358013180890683
LIPASE DEFICIENCY, COMBINED	0.00408163	0.20358013180890683
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.20358013180890683
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.20358013180890683
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.20358013180890683
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.20358013180890683
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.20358013180890683
GONADOBLASTOMA	0.00408163	0.20358013180890683
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.20358013180890683
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.20358013180890683
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.20358013180890683
APOLIPOPROTEIN(A)	0.00408163	0.20358013180890683
CHROMOSOME 16p13.3 DELETION SYNDROME	0.004061142	0.20255824845825995
HOLOPROSENCEPHALY 2; HPE2	0.004061142	0.20255824845825995
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.004061142	0.20255824845825995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.004061142	0.20255824845825995
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.004061142	0.20255824845825995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.004061142	0.20255824845825995
CEREBELLOFACIODENTAL SYNDROME	0.004061142	0.20255824845825995
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.004061142	0.20255824845825995
JABERI-ELAHI SYNDROME; JABELS	0.004061142	0.20255824845825995
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.004061142	0.20255824845825995
KLEEFSTRA SYNDROME 2; KLEFS2	0.004061142	0.20255824845825995
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004061142	0.20255824845825995
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.004061142	0.20255824845825995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004061142	0.20255824845825995
Congenital disorder of glycosylation, type IIh	0.004061142	0.20255824845825995
ALAZAMI SYNDROME; ALAZS	0.004061142	0.20255824845825995
Pierpont syndrome	0.004061142	0.20255824845825995
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004061142	0.20255824845825995
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004061142	0.20255824845825995
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004061142	0.20255824845825995
BETA-UREIDOPROPIONASE DEFICIENCY	0.004061142	0.20255824845825995
MARINESCO-SJOGREN SYNDROME; MSS	0.004061142	0.20255824845825995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.004061142	0.20255824845825995
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.004061142	0.20255824845825995
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.004028592	0.20093474674684075
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.004028592	0.20093474674684075
NIEMANN-PICK DISEASE, TYPE C2	0.004028592	0.20093474674684075
CITRULLINEMIA, CLASSIC	0.004028592	0.20093474674684075
PEROXISOME BIOGENESIS DISORDER 3B	0.004028592	0.20093474674684075
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004028592	0.20093474674684075
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.004028592	0.20093474674684075
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.004028592	0.20093474674684075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.004028592	0.20093474674684075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.004028592	0.20093474674684075
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.004028592	0.20093474674684075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.004028592	0.20093474674684075
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.004028592	0.20093474674684075
MACROCEPHALY/AUTISM SYNDROME	0.004028592	0.20093474674684075
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.004028592	0.20093474674684075
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004028592	0.20093474674684075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004028592	0.20093474674684075
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.004028592	0.20093474674684075
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.004028592	0.20093474674684075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.004028592	0.20093474674684075
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.004028592	0.20093474674684075
NAVAJO NEUROHEPATOPATHY	0.004028592	0.20093474674684075
PYRUVATE CARBOXYLASE DEFICIENCY	0.004028592	0.20093474674684075
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.004028592	0.20093474674684075
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.004028592	0.20093474674684075
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.004028592	0.20093474674684075
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.004028592	0.20093474674684075
ARIMA SYNDROME	0.004028592	0.20093474674684075
GAUCHER DISEASE, TYPE II	0.004028592	0.20093474674684075
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004028592	0.20093474674684075
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.004028592	0.20093474674684075
NIEMANN-PICK DISEASE, TYPE A	0.004028592	0.20093474674684075
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004028592	0.20093474674684075
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00321726	0.1604678069456378
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00321726	0.1604678069456378
AICARDI SYNDROME; AIC	0.00321726	0.1604678069456378
HALLERMANN-STREIFF SYNDROME; HSS	0.00321726	0.1604678069456378
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00321726	0.1604678069456378
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00321726	0.1604678069456378
MENTAL RETARDATION, X-LINKED 102	0.00321726	0.1604678069456378
XFE PROGEROID SYNDROME; XFEPS	0.00321726	0.1604678069456378
MARDEN-WALKER SYNDROME	0.00321726	0.1604678069456378
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00321726	0.1604678069456378
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00321726	0.1604678069456378
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00321726	0.1604678069456378
NEU-LAXOVA SYNDROME 2; NLS2	0.00321726	0.1604678069456378
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00321726	0.1604678069456378
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00321726	0.1604678069456378
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00321726	0.1604678069456378
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00321726	0.1604678069456378
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00321726	0.1604678069456378
RUVALCABA SYNDROME	0.00321726	0.1604678069456378
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00321726	0.1604678069456378
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00321726	0.1604678069456378
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00321726	0.1604678069456378
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00321726	0.1604678069456378
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00321726	0.1604678069456378
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00321726	0.1604678069456378
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00321726	0.1604678069456378
CRANIOECTODERMAL DYSPLASIA 1	0.00318471	0.1588443052342186
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00318471	0.1588443052342186
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00318471	0.1588443052342186
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00318471	0.1588443052342186
GAUCHER DISEASE, TYPE I	0.00318471	0.1588443052342186
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00318471	0.1588443052342186
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00318471	0.1588443052342186
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00318471	0.1588443052342186
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00318471	0.1588443052342186
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00318471	0.1588443052342186
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00318471	0.1588443052342186
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00318471	0.1588443052342186
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00318471	0.1588443052342186
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.00318471	0.1588443052342186
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00318471	0.1588443052342186
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00318471	0.1588443052342186
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00318471	0.1588443052342186
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00318471	0.1588443052342186
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00318471	0.1588443052342186
HEMOCHROMATOSIS, TYPE 2A	0.00318471	0.1588443052342186
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00318471	0.1588443052342186
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00318471	0.1588443052342186
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.00318471	0.1588443052342186
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00318471	0.1588443052342186
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00318471	0.1588443052342186
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00318471	0.1588443052342186
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00318471	0.1588443052342186
TRICHOHEPATOENTERIC SYNDROME 1	0.00318471	0.1588443052342186
LIVER FAILURE, INFANTILE, TRANSIENT	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00318471	0.1588443052342186
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00318471	0.1588443052342186
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00318471	0.1588443052342186
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE IB	0.00318471	0.1588443052342186
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00318471	0.1588443052342186
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00318471	0.1588443052342186
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00318471	0.1588443052342186
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00318471	0.1588443052342186
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00318471	0.1588443052342186
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE IA	0.00318471	0.1588443052342186
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00318471	0.1588443052342186
CHANARIN-DORFMAN SYNDROME	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00318471	0.1588443052342186
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00318471	0.1588443052342186
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00318471	0.1588443052342186
GAUCHER DISEASE, TYPE IIIC	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00318471	0.1588443052342186
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00318471	0.1588443052342186
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00318471	0.1588443052342186
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00318471	0.1588443052342186
NIEMANN-PICK DISEASE, TYPE B	0.00318471	0.1588443052342186
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00318471	0.1588443052342186
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00318471	0.1588443052342186
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00318471	0.1588443052342186
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00318471	0.1588443052342186
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00318471	0.1588443052342186
CAROLI DISEASE, ISOLATED	0.00318471	0.1588443052342186
APOLIPOPROTEIN C-II DEFICIENCY	0.00318471	0.1588443052342186
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00318471	0.1588443052342186
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.00318471	0.1588443052342186
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00318471	0.1588443052342186
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.00318471	0.1588443052342186
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00318471	0.1588443052342186
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00318471	0.1588443052342186
#615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	0.00318471	0.1588443052342186
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE VI	0.00318471	0.1588443052342186
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00318471	0.1588443052342186
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00318471	0.1588443052342186
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00318471	0.1588443052342186
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00318471	0.1588443052342186
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.00318471	0.1588443052342186
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00318471	0.1588443052342186
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00318471	0.1588443052342186
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00318471	0.1588443052342186
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.00318471	0.1588443052342186
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE II	0.00318471	0.1588443052342186
Polyarteritis nodosa, childhood-onset	0.00318471	0.1588443052342186
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00318471	0.1588443052342186
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00318471	0.1588443052342186
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318471	0.1588443052342186
HEMOCHROMATOSIS, TYPE 2B	0.00318471	0.1588443052342186
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE IXC	0.00318471	0.1588443052342186
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00318471	0.1588443052342186
HEMOCHROMATOSIS, TYPE 1	0.00318471	0.1588443052342186
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00318471	0.1588443052342186
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00318471	0.1588443052342186
NEPHRONOPHTHISIS 19; NPHP19	0.00318471	0.1588443052342186
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00318471	0.1588443052342186
PORTAL HYPERTENSION, NONCIRRHOTIC	0.00318471	0.1588443052342186
SCLEROSING CHOLANGITIS, NEONATAL	0.00318471	0.1588443052342186
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00318471	0.1588443052342186
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00318471	0.1588443052342186
REYNOLDS SYNDROME	0.00318471	0.1588443052342186
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00318471	0.1588443052342186
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00318471	0.1588443052342186
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00318471	0.1588443052342186
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.00318471	0.1588443052342186
SICKLE CELL ANEMIA	0.00318471	0.1588443052342186
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00318471	0.1588443052342186
TRICHOHEPATOENTERIC SYNDROME 2	0.00318471	0.1588443052342186
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00318471	0.1588443052342186
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00318471	0.1588443052342186
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00318471	0.1588443052342186
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.00318471	0.1588443052342186
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00318471	0.1588443052342186
#613977 CYANOSIS, TRANSIENT NEONATAL; TNCY	0.00318471	0.1588443052342186
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00318471	0.1588443052342186
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00318471	0.1588443052342186
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00318471	0.1588443052342186
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00318471	0.1588443052342186
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00318471	0.1588443052342186
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00318471	0.1588443052342186
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00318471	0.1588443052342186
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00318471	0.1588443052342186
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.00318471	0.1588443052342186
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00318471	0.1588443052342186
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00318471	0.1588443052342186
IMMUNODEFICIENCY 47	0.00318471	0.1588443052342186
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00318471	0.1588443052342186
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00318471	0.1588443052342186
COMBINED SAPOSIN DEFICIENCY	0.00318471	0.1588443052342186
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00318471	0.1588443052342186
RETINITIS PIGMENTOSA 59; RP59	0.00318471	0.1588443052342186
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00318471	0.1588443052342186
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.00318471	0.1588443052342186
TANGIER DISEASE; TGD	0.00318471	0.1588443052342186
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.00318471	0.1588443052342186
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00318471	0.1588443052342186
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00318471	0.1588443052342186
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.00318471	0.1588443052342186
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00318471	0.1588443052342186
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00318471	0.1588443052342186
HYPERLIPOPROTEINEMIA, TYPE ID	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE IXB	0.00318471	0.1588443052342186
GLYCOGEN STORAGE DISEASE IXA	0.00318471	0.1588443052342186
POLYCYSTIC LIVER DISEASE 2	0.00318471	0.1588443052342186
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.00318471	0.1588443052342186
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00318471	0.1588443052342186
TYROSINEMIA, TYPE I; TYRSN1	0.00318471	0.1588443052342186
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0027856319999999997	0.1389394260947486
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0027856319999999997	0.1389394260947486
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0027856319999999997	0.1389394260947486
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.0027856319999999997	0.1389394260947486
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.0027856319999999997	0.1389394260947486
WEAVER SYNDROME	0.0027856319999999997	0.1389394260947486
Pontine tegmental cap dysplasia	0.0027856319999999997	0.1389394260947486
JOUBERT SYNDROME 7	0.0027856319999999997	0.1389394260947486
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0027856319999999997	0.1389394260947486
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.0027856319999999997	0.1389394260947486
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0027856319999999997	0.1389394260947486
LAMB-SHAFFER SYNDROME	0.0027856319999999997	0.1389394260947486
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.0027856319999999997	0.1389394260947486
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.0027856319999999997	0.1389394260947486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0027856319999999997	0.1389394260947486
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0027856319999999997	0.1389394260947486
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0027856319999999997	0.1389394260947486
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.0027856319999999997	0.1389394260947486
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0027856319999999997	0.1389394260947486
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0027856319999999997	0.1389394260947486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0027856319999999997	0.1389394260947486
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0027856319999999997	0.1389394260947486
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0027856319999999997	0.1389394260947486
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.0027856319999999997	0.1389394260947486
BAKER-GORDON SYNDROME; BAGOS	0.0027856319999999997	0.1389394260947486
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0027856319999999997	0.1389394260947486
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.0027856319999999997	0.1389394260947486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.0027856319999999997	0.1389394260947486
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.0027856319999999997	0.1389394260947486
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0027856319999999997	0.1389394260947486
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.0027856319999999997	0.1389394260947486
Aarskog-Scott syndrome	0.0027856319999999997	0.1389394260947486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.0027856319999999997	0.1389394260947486
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0027856319999999997	0.1389394260947486
POPOV-CHANG SYNDROME; POPCHAS	0.0027856319999999997	0.1389394260947486
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0027856319999999997	0.1389394260947486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0027856319999999997	0.1389394260947486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.0027856319999999997	0.1389394260947486
ANGELMAN SYNDROME	0.0027856319999999997	0.1389394260947486
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027856319999999997	0.1389394260947486
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.0027856319999999997	0.1389394260947486
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0027856319999999997	0.1389394260947486
IMMUNODEFICIENCY 23; IMD23	0.0027856319999999997	0.1389394260947486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0021193920000000003	0.1057092638761335
VICI SYNDROME; VICIS	0.0021193920000000003	0.1057092638761335
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0021193920000000003	0.1057092638761335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0021193920000000003	0.1057092638761335
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0021193920000000003	0.1057092638761335
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021193920000000003	0.1057092638761335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0021193920000000003	0.1057092638761335
Xq28 (MECP2) duplication	0.0021193920000000003	0.1057092638761335
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0021193920000000003	0.1057092638761335
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0021193920000000003	0.1057092638761335
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0021193920000000003	0.1057092638761335
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0021193920000000003	0.1057092638761335
OPTIC ATROPHY 11; OPA11	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.1057092638761335
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0021193920000000003	0.1057092638761335
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0021193920000000003	0.1057092638761335
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.1057092638761335
RAINE SYNDROME	0.0021193920000000003	0.1057092638761335
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0021193920000000003	0.1057092638761335
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0021193920000000003	0.1057092638761335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0021193920000000003	0.1057092638761335
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0021193920000000003	0.1057092638761335
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0021193920000000003	0.1057092638761335
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0021193920000000003	0.1057092638761335
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0021193920000000003	0.1057092638761335
ADENYLOSUCCINASE DEFICIENCY	0.0021193920000000003	0.1057092638761335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0021193920000000003	0.1057092638761335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0021193920000000003	0.1057092638761335
FORSYTHE-WAKELING SYNDROME; FWS	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0021193920000000003	0.1057092638761335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0021193920000000003	0.1057092638761335
ADAMS-OLIVER SYNDROME 3; AOS3	0.0021193920000000003	0.1057092638761335
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0021193920000000003	0.1057092638761335
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0021193920000000003	0.1057092638761335
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0021193920000000003	0.1057092638761335
CHROMOSOME 19p13.13 DELETION SYNDROME	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0021193920000000003	0.1057092638761335
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0021193920000000003	0.1057092638761335
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0021193920000000003	0.1057092638761335
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0021193920000000003	0.1057092638761335
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0021193920000000003	0.1057092638761335
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.1057092638761335
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0021193920000000003	0.1057092638761335
LISSENCEPHALY 2; LIS2	0.0021193920000000003	0.1057092638761335
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0021193920000000003	0.1057092638761335
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.1057092638761335
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.0021193920000000003	0.1057092638761335
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0021193920000000003	0.1057092638761335
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0021193920000000003	0.1057092638761335
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0021193920000000003	0.1057092638761335
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0021193920000000003	0.1057092638761335
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0021193920000000003	0.1057092638761335
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0021193920000000003	0.1057092638761335
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0021193920000000003	0.1057092638761335
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.0021193920000000003	0.1057092638761335
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.1057092638761335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0021193920000000003	0.1057092638761335
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.0021193920000000003	0.1057092638761335
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0021193920000000003	0.1057092638761335
HEART AND BRAIN MALFORMATION SYNDROME	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0021193920000000003	0.1057092638761335
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.1057092638761335
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0021193920000000003	0.1057092638761335
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0021193920000000003	0.1057092638761335
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021193920000000003	0.1057092638761335
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0021193920000000003	0.1057092638761335
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0021193920000000003	0.1057092638761335
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0021193920000000003	0.1057092638761335
#614728 SECKEL SYNDROME 6; SCKL6	0.0021193920000000003	0.1057092638761335
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0021193920000000003	0.1057092638761335
WARSAW BREAKAGE SYNDROME; WABS	0.0021193920000000003	0.1057092638761335
AICARDI-GOUTIERES SYNDROME 5	0.0021193920000000003	0.1057092638761335
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0021193920000000003	0.1057092638761335
HOLOPROSENCEPHALY 1; HPE1	0.0021193920000000003	0.1057092638761335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0021193920000000003	0.1057092638761335
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0021193920000000003	0.1057092638761335
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.1057092638761335
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0021193920000000003	0.1057092638761335
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0021193920000000003	0.1057092638761335
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0021193920000000003	0.1057092638761335
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0021193920000000003	0.1057092638761335
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0021193920000000003	0.1057092638761335
HOLOPROSENCEPHALY 3; HPE3	0.0021193920000000003	0.1057092638761335
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0021193920000000003	0.1057092638761335
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0021193920000000003	0.1057092638761335
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021193920000000003	0.1057092638761335
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.0021193920000000003	0.1057092638761335
OROFACIODIGITAL SYNDROME IX; OFD9	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0021193920000000003	0.1057092638761335
LISSENCEPHALY 4	0.0021193920000000003	0.1057092638761335
HOLOPROSENCEPHALY 5; HPE5	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0021193920000000003	0.1057092638761335
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0021193920000000003	0.1057092638761335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0021193920000000003	0.1057092638761335
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0021193920000000003	0.1057092638761335
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0021193920000000003	0.1057092638761335
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.0021193920000000003	0.1057092638761335
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.0021193920000000003	0.1057092638761335
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0021193920000000003	0.1057092638761335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0021193920000000003	0.1057092638761335
GLASS SYNDROME	0.0021193920000000003	0.1057092638761335
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0021193920000000003	0.1057092638761335
PELIZAEUS-MERZBACHER DISEASE	0.0021193920000000003	0.1057092638761335
LISSENCEPHALY 8; LIS8	0.0021193920000000003	0.1057092638761335
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0021193920000000003	0.1057092638761335
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0021193920000000003	0.1057092638761335
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0021193920000000003	0.1057092638761335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021193920000000003	0.1057092638761335
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0021193920000000003	0.1057092638761335
HOLOPROSENCEPHALY 11	0.0021193920000000003	0.1057092638761335
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0021193920000000003	0.1057092638761335
AICARDI-GOUTIERES SYNDROME 6	0.0021193920000000003	0.1057092638761335
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0021193920000000003	0.1057092638761335
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0021193920000000003	0.1057092638761335
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0021193920000000003	0.1057092638761335
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0021193920000000003	0.1057092638761335
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0021193920000000003	0.1057092638761335
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0021193920000000003	0.1057092638761335
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0021193920000000003	0.1057092638761335
AL-RAQAD SYNDROME; ARS	0.0021193920000000003	0.1057092638761335
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0021193920000000003	0.1057092638761335
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.1057092638761335
HARTSFIELD SYNDROME; HRTFDS	0.0021193920000000003	0.1057092638761335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0021193920000000003	0.1057092638761335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0021193920000000003	0.1057092638761335
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0021193920000000003	0.1057092638761335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0021193920000000003	0.1057092638761335
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0021193920000000003	0.1057092638761335
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.0021193920000000003	0.1057092638761335
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0021193920000000003	0.1057092638761335
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0021193920000000003	0.1057092638761335
GOLDBERG-SHPRINTZEN SYNDROME	0.0021193920000000003	0.1057092638761335
RING CHROMOSOME 14 SYNDROME	0.0021193920000000003	0.1057092638761335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0021193920000000003	0.1057092638761335
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0021193920000000003	0.1057092638761335
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.1057092638761335
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.1057092638761335
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0021193920000000003	0.1057092638761335
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0021193920000000003	0.1057092638761335
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.1057092638761335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021193920000000003	0.1057092638761335
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0021193920000000003	0.1057092638761335
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021193920000000003	0.1057092638761335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.0021193920000000003	0.1057092638761335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0021193920000000003	0.1057092638761335
CHROMOSOME 1p35 DELETION SYNDROME	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0021193920000000003	0.1057092638761335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0021193920000000003	0.1057092638761335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.0021193920000000003	0.1057092638761335
#615731 NEMALINE MYOPATHY 9; NEM9	0.00194175	0.09684898458212647
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00194175	0.09684898458212647
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.00194175	0.09684898458212647
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00194175	0.09684898458212647
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00194175	0.09684898458212647
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00194175	0.09684898458212647
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.00194175	0.09684898458212647
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00194175	0.09684898458212647
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00194175	0.09684898458212647
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.00194175	0.09684898458212647
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00194175	0.09684898458212647
NOONAN SYNDROME 4; NS4	0.00194175	0.09684898458212647
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00194175	0.09684898458212647
MYOCLONIC-ATONIC EPILEPSY	0.00194175	0.09684898458212647
CHROMOSOME 17q12 DELETION SYNDROME	0.00194175	0.09684898458212647
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00194175	0.09684898458212647
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.00194175	0.09684898458212647
NEMALINE MYOPATHY 1; NEM1	0.00194175	0.09684898458212647
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00194175	0.09684898458212647
RAMON SYNDROME	0.00194175	0.09684898458212647
OPSISMODYSPLASIA; OPSMD	0.00194175	0.09684898458212647
MARFANOID HYPERMOBILITY SYNDROME	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00194175	0.09684898458212647
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.00194175	0.09684898458212647
PYLE DISEASE; PYL	0.00194175	0.09684898458212647
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00194175	0.09684898458212647
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00194175	0.09684898458212647
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00194175	0.09684898458212647
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00194175	0.09684898458212647
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00194175	0.09684898458212647
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00194175	0.09684898458212647
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00194175	0.09684898458212647
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00194175	0.09684898458212647
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00194175	0.09684898458212647
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00194175	0.09684898458212647
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00194175	0.09684898458212647
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00194175	0.09684898458212647
NEMALINE MYOPATHY 2; NEM2	0.00194175	0.09684898458212647
#168400 PARASTREMMATIC DWARFISM	0.00194175	0.09684898458212647
TOWNES-BROCKS SYNDROME 2; TBS2	0.00194175	0.09684898458212647
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00194175	0.09684898458212647
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.00194175	0.09684898458212647
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00194175	0.09684898458212647
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.00194175	0.09684898458212647
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00194175	0.09684898458212647
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.00194175	0.09684898458212647
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00194175	0.09684898458212647
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.00194175	0.09684898458212647
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00194175	0.09684898458212647
LEBER OPTIC ATROPHY AND DYSTONIA	0.00194175	0.09684898458212647
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00194175	0.09684898458212647
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00194175	0.09684898458212647
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00194175	0.09684898458212647
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00194175	0.09684898458212647
#614434 CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	0.00194175	0.09684898458212647
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00194175	0.09684898458212647
SPRENGEL DEFORMITY	0.00194175	0.09684898458212647
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00194175	0.09684898458212647
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00194175	0.09684898458212647
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00194175	0.09684898458212647
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00194175	0.09684898458212647
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00194175	0.09684898458212647
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.00194175	0.09684898458212647
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.00194175	0.09684898458212647
MARFANOID HABITUS WITH SITUS INVERSUS	0.00194175	0.09684898458212647
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00194175	0.09684898458212647
SYRINGOMYELIA, ISOLATED	0.00194175	0.09684898458212647
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00194175	0.09684898458212647
SALIH MYOPATHY; SALMY	0.00194175	0.09684898458212647
CLEIDOCRANIAL DYSPLASIA; CCD	0.00194175	0.09684898458212647
STICKLER SYNDROME, TYPE I	0.00194175	0.09684898458212647
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00194175	0.09684898458212647
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00194175	0.09684898458212647
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00194175	0.09684898458212647
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00194175	0.09684898458212647
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00194175	0.09684898458212647
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00194175	0.09684898458212647
IVIC SYNDROME	0.00194175	0.09684898458212647
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00194175	0.09684898458212647
RETT SYNDROME; RTT	0.00194175	0.09684898458212647
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00194175	0.09684898458212647
CAMURATI-ENGELMANN DISEASE	0.00194175	0.09684898458212647
TIBIAL TORSION, BILATERAL MEDIAL	0.00194175	0.09684898458212647
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00194175	0.09684898458212647
Osteogenesis imperfecta, type IX	0.00194175	0.09684898458212647
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00194175	0.09684898458212647
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00194175	0.09684898458212647
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00194175	0.09684898458212647
MYOPATHY, SCAPULOHUMEROPERONEAL	0.00194175	0.09684898458212647
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00194175	0.09684898458212647
SPONDYLOCOSTAL DYSOSTOSIS 5	0.00194175	0.09684898458212647
CZECH DYSPLASIA, METATARSAL TYPE	0.00194175	0.09684898458212647
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00194175	0.09684898458212647
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00194175	0.09684898458212647
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00194175	0.09684898458212647
PSEUDOACHONDROPLASIA	0.00194175	0.09684898458212647
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00194175	0.09684898458212647
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.00194175	0.09684898458212647
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00194175	0.09684898458212647
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00194175	0.09684898458212647
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00194175	0.09684898458212647
OROFACIODIGITAL SYNDROME V; OFD5	0.00194175	0.09684898458212647
Mulchandani-Bhoj-Conlin syndrome	0.00194175	0.09684898458212647
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00194175	0.09684898458212647
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00194175	0.09684898458212647
STUVE-WIEDEMANN SYNDROME	0.00194175	0.09684898458212647
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00194175	0.09684898458212647
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00194175	0.09684898458212647
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00194175	0.09684898458212647
SOTOS SYNDROME 2	0.00194175	0.09684898458212647
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00194175	0.09684898458212647
COFFIN-SIRIS SYNDROME 8; CSS8	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00194175	0.09684898458212647
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00194175	0.09684898458212647
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.00194175	0.09684898458212647
CHIARI MALFORMATION TYPE I	0.00194175	0.09684898458212647
LERI-WEILL DYSCHONDROSTEOSIS	0.00194175	0.09684898458212647
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00194175	0.09684898458212647
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00194175	0.09684898458212647
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00194175	0.09684898458212647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00194175	0.09684898458212647
THORACOLARYNGOPELVIC DYSPLASIA	0.00194175	0.09684898458212647
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00194175	0.09684898458212647
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00194175	0.09684898458212647
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00194175	0.09684898458212647
MENTAL RETARDATION, X-LINKED 82	0.00194175	0.09684898458212647
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00194175	0.09684898458212647
NEMALINE MYOPATHY 3; NEM3	0.00194175	0.09684898458212647
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00194175	0.09684898458212647
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00194175	0.09684898458212647
ODONTOCHONDRODYSPLASIA; ODCD	0.00194175	0.09684898458212647
RETT SYNDROME, CONGENITAL VARIANT	0.00194175	0.09684898458212647
POSTERIOR COLUMN ATAXIA	0.00194175	0.09684898458212647
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00194175	0.09684898458212647
SHPRINTZEN OMPHALOCELE SYNDROME	0.00194175	0.09684898458212647
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00194175	0.09684898458212647
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00194175	0.09684898458212647
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00194175	0.09684898458212647
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00194175	0.09684898458212647
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.00194175	0.09684898458212647
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.00194175	0.09684898458212647
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00194175	0.09684898458212647
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00194175	0.09684898458212647
METATROPIC DYSPLASIA	0.00194175	0.09684898458212647
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00194175	0.09684898458212647
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00194175	0.09684898458212647
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00194175	0.09684898458212647
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00194175	0.09684898458212647
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.00194175	0.09684898458212647
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00194175	0.09684898458212647
FACIOCARDIORENAL SYNDROME	0.00194175	0.09684898458212647
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00194175	0.09684898458212647
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00194175	0.09684898458212647
#259450 BRUCK SYNDROME 1; BRKS1	0.00194175	0.09684898458212647
SPONDYLOCAMPTODACTYLY	0.00194175	0.09684898458212647
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.00194175	0.09684898458212647
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00194175	0.09684898458212647
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00194175	0.09684898458212647
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00194175	0.09684898458212647
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00194175	0.09684898458212647
HEMIHYPERPLASIA, ISOLATED	0.00194175	0.09684898458212647
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00194175	0.09684898458212647
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00194175	0.09684898458212647
231970 GLUTEAL MUSCLES, ABSENCE OF	0.00194175	0.09684898458212647
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00194175	0.09684898458212647
OSTEOGENESIS IMPERFECTA, TYPE X	0.00194175	0.09684898458212647
NEUROFIBROMATOSIS, TYPE I	0.00194175	0.09684898458212647
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.00194175	0.09684898458212647
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00194175	0.09684898458212647
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00194175	0.09684898458212647
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00194175	0.09684898458212647
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00194175	0.09684898458212647
VERVERI-BRADY SYNDROME; VERBRAS	0.00127551	0.06361882236351134
Wolf-Hirschhorn Syndrome	0.00127551	0.06361882236351134
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.06361882236351134
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.06361882236351134
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00127551	0.06361882236351134
BLOOM SYNDROME	0.00127551	0.06361882236351134
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00127551	0.06361882236351134
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.06361882236351134
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.06361882236351134
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.06361882236351134
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.00127551	0.06361882236351134
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00127551	0.06361882236351134
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.06361882236351134
SECKEL SYNDROME 2; SCKL2	0.00127551	0.06361882236351134
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00127551	0.06361882236351134
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00127551	0.06361882236351134
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00127551	0.06361882236351134
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00127551	0.06361882236351134
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00127551	0.06361882236351134
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00127551	0.06361882236351134
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.06361882236351134
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.06361882236351134
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00127551	0.06361882236351134
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00127551	0.06361882236351134
MEIER-GORLIN SYNDROME 3; MGORS3	0.00127551	0.06361882236351134
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.06361882236351134
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.06361882236351134
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.06361882236351134
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.06361882236351134
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.06361882236351134
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.06361882236351134
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.06361882236351134
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00127551	0.06361882236351134
KEARNS-SAYRE SYNDROME; KSS	0.00127551	0.06361882236351134
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00127551	0.06361882236351134
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.06361882236351134
ADDUCTED THUMBS SYNDROME	0.00127551	0.06361882236351134
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.06361882236351134
2p15-16.1 microdeletion syndrome	0.00127551	0.06361882236351134
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00127551	0.06361882236351134
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00127551	0.06361882236351134
MICROCEPHALY-CARDIOMYOPATHY	0.00127551	0.06361882236351134
MECKEL SYNDROME 12; MKS12	0.00127551	0.06361882236351134
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.06361882236351134
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.06361882236351134
PERRAULT SYNDROME 3	0.00127551	0.06361882236351134
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.06361882236351134
BARDET-BIEDL SYNDROME 20	0.00127551	0.06361882236351134
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00127551	0.06361882236351134
DE SANCTIS-CACCHIONE SYNDROME	0.00127551	0.06361882236351134
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00127551	0.06361882236351134
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00127551	0.06361882236351134
LAMBOTTE SYNDROME	0.00127551	0.06361882236351134
SECKEL SYNDROME 10; SCKL10	0.00127551	0.06361882236351134
SECKEL SYNDROME 5; SCKL5	0.00127551	0.06361882236351134
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.06361882236351134
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00127551	0.06361882236351134
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00127551	0.06361882236351134
HYPERREFLEXIA	0.00127551	0.06361882236351134
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00127551	0.06361882236351134
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.06361882236351134
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00127551	0.06361882236351134
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00127551	0.06361882236351134
Angelman syndrome (Type 2)	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.06361882236351134
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00127551	0.06361882236351134
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.06361882236351134
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.06361882236351134
Angelman syndrome (Type 1)	0.00127551	0.06361882236351134
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.06361882236351134
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00127551	0.06361882236351134
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00127551	0.06361882236351134
LISSENCEPHALY 3; LIS3	0.00127551	0.06361882236351134
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.06361882236351134
DUBOWITZ SYNDROME	0.00127551	0.06361882236351134
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00127551	0.06361882236351134
MASA SYNDROME	0.00127551	0.06361882236351134
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.06361882236351134
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00127551	0.06361882236351134
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00127551	0.06361882236351134
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.06361882236351134
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.06361882236351134
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.06361882236351134
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00127551	0.06361882236351134
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.06361882236351134
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.06361882236351134
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00127551	0.06361882236351134
MICROPHTHALMIA, SYNDROMIC 1	0.00127551	0.06361882236351134
MENKES DISEASE	0.00127551	0.06361882236351134
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.06361882236351134
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.06361882236351134
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00127551	0.06361882236351134
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00127551	0.06361882236351134
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00127551	0.06361882236351134
FRONTONASAL DYSPLASIA 2; FND2	0.00127551	0.06361882236351134
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00127551	0.06361882236351134
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00127551	0.06361882236351134
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.06361882236351134
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.06361882236351134
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00127551	0.06361882236351134
PAINE SYNDROME	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00127551	0.06361882236351134
GERODERMA OSTEODYSPLASTICUM; GO	0.00127551	0.06361882236351134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00127551	0.06361882236351134
#615328 SHAHEEN SYNDROME; SHNS	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.06361882236351134
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.06361882236351134
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.06361882236351134
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.06361882236351134
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.06361882236351134
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.06361882236351134
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00127551	0.06361882236351134
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00127551	0.06361882236351134
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00127551	0.06361882236351134
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.06361882236351134
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00127551	0.06361882236351134
SUPRABULBAR PARESIS, CONGENITAL	0.00127551	0.06361882236351134
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.06361882236351134
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.06361882236351134
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00127551	0.06361882236351134
PHENYLKETONURIA	0.00127551	0.06361882236351134
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.06361882236351134
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00127551	0.06361882236351134
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.06361882236351134
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.06361882236351134
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00127551	0.06361882236351134
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.06361882236351134
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00127551	0.06361882236351134
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.06361882236351134
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.06361882236351134
FILIPPI SYNDROME; FLPIS	0.00127551	0.06361882236351134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00127551	0.06361882236351134
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00127551	0.06361882236351134
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00127551	0.06361882236351134
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.06361882236351134
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.06361882236351134
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00127551	0.06361882236351134
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00127551	0.06361882236351134
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00127551	0.06361882236351134
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00127551	0.06361882236351134
FEINGOLD SYNDROME 2; FGLDS2	0.00127551	0.06361882236351134
MARTSOLF SYNDROME	0.00127551	0.06361882236351134
15q24 recurrent microdeletion syndrome	0.00127551	0.06361882236351134
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.06361882236351134
Cri du Chat Syndrome (5p deletion)	0.00127551	0.06361882236351134
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00127551	0.06361882236351134
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00127551	0.06361882236351134
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.06361882236351134
COFFIN-SIRIS SYNDROME 10; CSS10	0.00127551	0.06361882236351134
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00127551	0.06361882236351134
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00127551	0.06361882236351134
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.06361882236351134
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.06361882236351134
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00127551	0.06361882236351134
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.06361882236351134
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00127551	0.06361882236351134
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00127551	0.06361882236351134
INCONTINENTIA PIGMENTI; IP	0.00127551	0.06361882236351134
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.06361882236351134
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00127551	0.06361882236351134
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00127551	0.06361882236351134
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00127551	0.06361882236351134
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.06361882236351134
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00127551	0.06361882236351134
MICROHYDRANENCEPHALY; MHAC	0.00127551	0.06361882236351134
VELOCARDIOFACIAL SYNDROME	0.00127551	0.06361882236351134
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00127551	0.06361882236351134
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.06361882236351134
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.06361882236351134
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.06361882236351134
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.06361882236351134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.06361882236351134
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.06361882236351134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00127551	0.06361882236351134
SAY SYNDROME	0.00127551	0.06361882236351134
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.06361882236351134
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.06361882236351134
SECKEL SYNDROME 4	0.00127551	0.06361882236351134
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.06361882236351134
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00127551	0.06361882236351134
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.06361882236351134
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.06361882236351134
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.06361882236351134
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00127551	0.06361882236351134
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.06361882236351134
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00127551	0.06361882236351134
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.06361882236351134
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.06361882236351134
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00127551	0.06361882236351134
FACIOCARDIOMELIC SYNDROME	0.00127551	0.06361882236351134
WARBURG MICRO SYNDROME 1	0.00127551	0.06361882236351134
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.06361882236351134
LATHOSTEROLOSIS	0.00127551	0.06361882236351134
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.06361882236351134
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00127551	0.06361882236351134
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.06361882236351134
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00127551	0.06361882236351134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00127551	0.06361882236351134
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00127551	0.06361882236351134
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00127551	0.06361882236351134
STROMME SYNDROME; STROMS	0.00127551	0.06361882236351134
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00127551	0.06361882236351134
CYCLIC VOMITING SYNDROME	0.00127551	0.06361882236351134
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00127551	0.06361882236351134
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.06361882236351134
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00127551	0.06361882236351134
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00127551	0.06361882236351134
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00127551	0.06361882236351134
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00127551	0.06361882236351134
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00127551	0.06361882236351134
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.06361882236351134
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00127551	0.06361882236351134
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00127551	0.06361882236351134
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.042090441512622145
JOUBERT SYNDROME 1	0.000843882	0.042090441512622145
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.042090441512622145
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.042090441512622145
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000843882	0.042090441512622145
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.042090441512622145
PELLAGRA-LIKE SYNDROME	0.000843882	0.042090441512622145
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.042090441512622145
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000843882	0.042090441512622145
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.042090441512622145
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000843882	0.042090441512622145
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.042090441512622145
Retinitis pigmentosa with or without skeletal anomalies	0.000843882	0.042090441512622145
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.042090441512622145
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000843882	0.042090441512622145
MECKEL SYNDROME 13; MKS13	0.000843882	0.042090441512622145
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000843882	0.042090441512622145
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.042090441512622145
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.042090441512622145
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.042090441512622145
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.042090441512622145
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.042090441512622145
PELGER-HUET ANOMALY; PHA	0.000843882	0.042090441512622145
SENIOR-LOKEN SYNDROME 9	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000843882	0.042090441512622145
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.042090441512622145
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.042090441512622145
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000843882	0.042090441512622145
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000843882	0.042090441512622145
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.042090441512622145
RAHMAN SYNDROME	0.000843882	0.042090441512622145
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.042090441512622145
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.042090441512622145
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.042090441512622145
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000843882	0.042090441512622145
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.042090441512622145
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.042090441512622145
MEND SYNDROME; MEND	0.000843882	0.042090441512622145
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.042090441512622145
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.042090441512622145
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.042090441512622145
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000843882	0.042090441512622145
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000843882	0.042090441512622145
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000843882	0.042090441512622145
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.042090441512622145
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.042090441512622145
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.042090441512622145
SULFOCYSTEINURIA	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.042090441512622145
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.042090441512622145
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000843882	0.042090441512622145
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.042090441512622145
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.042090441512622145
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.042090441512622145
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.042090441512622145
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000843882	0.042090441512622145
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.042090441512622145
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.042090441512622145
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.042090441512622145
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.042090441512622145
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.042090441512622145
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.042090441512622145
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.042090441512622145
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.042090441512622145
LEIGH SYNDROME; LS	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.042090441512622145
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.042090441512622145
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000843882	0.042090441512622145
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.042090441512622145
OROFACIODIGITAL SYNDROME VI	0.000843882	0.042090441512622145
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.042090441512622145
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.042090441512622145
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.042090441512622145
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.042090441512622145
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.042090441512622145
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000843882	0.042090441512622145
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000843882	0.042090441512622145
ROIFMAN-CHITAYAT SYNDROME	0.000843882	0.042090441512622145
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.042090441512622145
JOUBERT SYNDROME 6	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000843882	0.042090441512622145
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000843882	0.042090441512622145
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000843882	0.042090441512622145
ELSAHY-WATERS SYNDROME; ESWS	0.000843882	0.042090441512622145
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.042090441512622145
Temtamy preaxial brachydactyly syndrome	0.000843882	0.042090441512622145
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.042090441512622145
FRIAS SYNDROME	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.042090441512622145
Jawad syndrome	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.042090441512622145
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.042090441512622145
JOUBERT SYNDROME 2	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000843882	0.042090441512622145
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.042090441512622145
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000843882	0.042090441512622145
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.042090441512622145
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.042090441512622145
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000843882	0.042090441512622145
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.042090441512622145
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.042090441512622145
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000843882	0.042090441512622145
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.042090441512622145
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.042090441512622145
CDAGS SYNDROME	0.000843882	0.042090441512622145
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.042090441512622145
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.042090441512622145
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.042090441512622145
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.042090441512622145
JOUBERT SYNDROME 14	0.000843882	0.042090441512622145
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.042090441512622145
GLYCEROL KINASE DEFICIENCY; GKD	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000843882	0.042090441512622145
JOUBERT SYNDROME 30; JBTS30	0.000843882	0.042090441512622145
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.042090441512622145
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.042090441512622145
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.042090441512622145
JOUBERT SYNDROME 28	0.000843882	0.042090441512622145
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000843882	0.042090441512622145
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.042090441512622145
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.042090441512622145
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.042090441512622145
Cerebral creatine deficiency syndrome 2	0.000843882	0.042090441512622145
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.042090441512622145
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.042090441512622145
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.042090441512622145
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.042090441512622145
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.042090441512622145
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000843882	0.042090441512622145
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000843882	0.042090441512622145
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.042090441512622145
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 90	0.000843882	0.042090441512622145
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000843882	0.042090441512622145
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.042090441512622145
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000843882	0.042090441512622145
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.042090441512622145
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.042090441512622145
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.042090441512622145
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000843882	0.042090441512622145
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.042090441512622145
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.042090441512622145
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000843882	0.042090441512622145
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.042090441512622145
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.042090441512622145
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.042090441512622145
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000843882	0.042090441512622145
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.042090441512622145
NOONAN SYNDROME 6; NS6	0.000843882	0.042090441512622145
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.042090441512622145
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000843882	0.042090441512622145
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000843882	0.042090441512622145
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.042090441512622145
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.042090441512622145
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000843882	0.042090441512622145
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.042090441512622145
JOUBERT SYNDROME 27	0.000843882	0.042090441512622145
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000843882	0.042090441512622145
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.042090441512622145
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.042090441512622145
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.042090441512622145
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.042090441512622145
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000843882	0.042090441512622145
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.042090441512622145
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.042090441512622145
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000843882	0.042090441512622145
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.042090441512622145
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000843882	0.042090441512622145
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000843882	0.042090441512622145
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.042090441512622145
XQ25 DUPLICATION SYNDROME	0.000843882	0.042090441512622145
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000843882	0.042090441512622145
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000843882	0.042090441512622145
JOUBERT SYNDROME 8	0.000843882	0.042090441512622145
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.042090441512622145
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000843882	0.042090441512622145
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000843882	0.042090441512622145
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000843882	0.042090441512622145
WAARDENBURG-SHAH SYNDROME	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000843882	0.042090441512622145
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.042090441512622145
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.042090441512622145
CHROMOSOME 5Q12 DELETION SYNDROME	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000843882	0.042090441512622145
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.042090441512622145
WAISMAN SYNDROME; WSMN	0.000843882	0.042090441512622145
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.042090441512622145
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000843882	0.042090441512622145
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.042090441512622145
AUSTRALIA ANTIGEN	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.042090441512622145
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.042090441512622145
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.042090441512622145
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.042090441512622145
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.042090441512622145
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.042090441512622145
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.042090441512622145
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000843882	0.042090441512622145
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.042090441512622145
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.042090441512622145
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.042090441512622145
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.042090441512622145
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.042090441512622145
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.042090441512622145
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.042090441512622145
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000843882	0.042090441512622145
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.042090441512622145
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.042090441512622145
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.042090441512622145
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.042090441512622145
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.000843882	0.042090441512622145
SCHINDLER DISEASE, TYPE I	0.000843882	0.042090441512622145
LANDAU-KLEFFNER SYNDROME	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000843882	0.042090441512622145
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.042090441512622145
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.042090441512622145
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.042090441512622145
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.042090441512622145
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.042090441512622145
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000843882	0.042090441512622145
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.042090441512622145
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.042090441512622145
JOUBERT SYNDROME 15	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000843882	0.042090441512622145
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.042090441512622145
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.042090441512622145
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.042090441512622145
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.042090441512622145
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 9	0.000843882	0.042090441512622145
JOUBERT SYNDROME 25	0.000843882	0.042090441512622145
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.042090441512622145
JOUBERT SYNDROME 21	0.000843882	0.042090441512622145
ELEJALDE DISEASE	0.000843882	0.042090441512622145
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.042090441512622145
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.042090441512622145
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000843882	0.042090441512622145
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.042090441512622145
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.042090441512622145
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.042090441512622145
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.042090441512622145
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.042090441512622145
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.042090441512622145
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.042090441512622145
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.042090441512622145
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.042090441512622145
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.042090441512622145
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000843882	0.042090441512622145
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.042090441512622145
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.042090441512622145
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.042090441512622145
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.042090441512622145
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.042090441512622145
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.042090441512622145
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.042090441512622145
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.042090441512622145
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.042090441512622145
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.042090441512622145
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000843882	0.042090441512622145
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.042090441512622145
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000843882	0.042090441512622145
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000843882	0.042090441512622145
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000843882	0.042090441512622145
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000843882	0.042090441512622145
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.042090441512622145
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000843882	0.042090441512622145
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000843882	0.042090441512622145
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000843882	0.042090441512622145
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.042090441512622145
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.042090441512622145
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.042090441512622145
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.042090441512622145
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.042090441512622145
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.042090441512622145
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.042090441512622145
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.042090441512622145
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000843882	0.042090441512622145
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.042090441512622145
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.042090441512622145
PEHO-LIKE SYNDROME; PEHOL	0.000843882	0.042090441512622145
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000843882	0.042090441512622145
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.042090441512622145
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.042090441512622145
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.042090441512622145
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.042090441512622145
PEHO SYNDROME; PEHO	0.000843882	0.042090441512622145
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000843882	0.042090441512622145
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.042090441512622145
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.042090441512622145
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.042090441512622145
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000843882	0.042090441512622145
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.042090441512622145
XIA-GIBBS SYNDROME	0.000843882	0.042090441512622145
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.042090441512622145
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.042090441512622145
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000843882	0.042090441512622145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.042090441512622145
CURRARINO SYNDROME	0.000843882	0.042090441512622145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.042090441512622145
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.042090441512622145
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.042090441512622145
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000843882	0.042090441512622145
CULLER-JONES SYNDROME; CJS	0.000843882	0.042090441512622145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000843882	0.042090441512622145
LISSENCEPHALY 1; LIS1	0.000843882	0.042090441512622145
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000843882	0.042090441512622145
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000843882	0.042090441512622145
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.042090441512622145
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.042090441512622145
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.042090441512622145
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.042090441512622145
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000843882	0.042090441512622145
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.042090441512622145
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000843882	0.042090441512622145
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.042090441512622145
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.042090441512622145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.042090441512622145
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000843882	0.042090441512622145
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.042090441512622145
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000843882	0.042090441512622145
